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Conservation of the balance between excitation and inhibition of neural
activity is critically important for the proper function of the nervous system. Upon
alterations in excitability, the nervous system may thus trigger mechanisms that
attempt to restore homeostasis. Many alcohols, anesthetics, and other abused volatile
solvents such as ethanol, benzyl alcohol, toluene, trichloroethylene, and chloroform
alter neural excitability and trigger homeostatic adaptations that through the
modulation of gene expression and signaling between nerve cells act to counteract
these alterations. Many of these adaptations may account for the development of
tolerance, dependence and addiction to these drugs. Here, I demonstrate that in
Drosophila, tolerance to the sedative effects of alcohols and anesthetics, is mediated
by an increase in expression of the Ca2+ activated K+ channel gene, slowpoke. A
mutation that eliminates slowpoke expression prevents tolerance, while expression
vi
from an inducible slowpoke transgene mimics tolerance in naive animals.
Furthermore, the behavioral and molecular response to volatile solvents can be
separated into an initial phase of hyperkinesis that causes a drop in slowpoke gene
expression and makes animals more sensitive to subsequent sedation by these drugs,
and a sedative phase that stimulates slowpoke gene expression and induces tolerance.
This demonstrates that the changes in expression level of slowpoke act as a modulator
of drug sensitivity. Because of it's central role as a regulator of electrical activity in
nerve terminals this channel gene is a likely contributor to the homeostatic
mechanism that resists untoward changes in net cellular excitability and mediates
tolerance to sedation. If hyperexcitability is induced, the proposed mechanism alters
channel expression to reduce this excitability, whereas if cellular excitability is
suppressed, channel gene expression changes to enhance excitability. An
electrophysiological test of this hypothesis shows that increased slowpoke expression
enhances the excitability of a neural pathway in a way that opposes the effects of
sedative drugs. This data supports the notion that slowpoke mediated tolerance to
sedation is part of a homeostatic adaptation that compensates for changes in neural
activity caused by drugs and represents a step forward in the understanding of the
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Chapter 1: General Introduction
The Foundation and Maintenance of Electrical Excitability in the 
Nervous System
Neural excitability is determined by voltage-gated ion channels
The ability of the nervous system to generate carefully coordinated
movements, perform complex computational tasks or exercise precise control over
physiological functions, relies on an exquisitely controlled balance between
excitatory and inhibitory signals within and between neurons.
The intrinsic excitability of a neuron is determined by the combination of ion
channels expressed in these cells. Ion channels are membrane spanning proteins that
form ion-selective pores that generally act to maintain an asymmetric distribution of
ions across the cellular surface membrane. Commonly, the concentration of sodium
(Na+) and calcium (Ca2+) ions is higher in the extra-cellular space while potassium
ions (K+) are more concentrated inside the cell resulting in the electrically polarized
state of a resting cell membrane. Additionally, ion channels display a wide variety of
biophysical characteristics that allow them to open and close in response to multiple
signals such as chemical neurotransmitters or small changes in the voltage potential
of the polarized resting state of the cell. The 'gating' properties of channels allow ions
to flow across their concentration and electrical gradients (Hille, 1992). 
When activated by small changes in voltage potentials, sodium and calcium
channels open transiently to allow these ions to flow into the cell causing a
depolarization of the cell membrane. The depolarization of the membrane potential in
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turn causes potassium channels to become activated and open to allow potassium ions
to flow out of the cell, resulting in the repolarization of the cell membrane. The
distribution of a series of these voltage-sensing (voltage-gated) channels along the
long projections (axons and dendrites) featured in neurons, allows the transient
conduction of ions, that depolarize and repolarize cell membranes, to become rapidly
propagated through these projections in the from of electrical regenerating pulses
called action potentials (Hille, 1992; Kandel et al., 1991).
When action potentials reach the nerve terminals, the depolarization causes a
significant rise in the intracellular calcium concentrations resulting from the
activation of membrane voltage-gated calcium channels or other intracellular calcium
stores. The increase in calcium levels is thought to mediate the exocytosis of chemical
neurotransmitters contained in small intracellular vesicles through the fusion of
vesicle to the surface membrane of axon terminals. The release of neurotransmitters
to the extracellular space between neurons (synapse) in turn, activates another class of
ion channels present in neighboring neurons that act as receptors to neurotransmitters.
These ion channels are often referred as ligand-gated ion channels and become
activated by neurotransmitter binding. Once activated, ligand-gated ion channels
allow the flow of certain ions into or out of the cell. The flow of ions may in some
cases cause the depolarization of the cell membrane and the generation of new action
potentials, or in other cases further polarize the cell membrane resulting in the
inhibition of the action potential generation (Kandel et al., 1991).
Although voltage- and ligand-gated ion channels can be divided into a few
number of classes based on their ion-selectivity (i.e. sodium, calcium, potassium
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amongst others) or on their ligand recognition, each class is actually composed of a
large family of channels with distinct biophysical characteristics. For example,
different channels exhibit different gating kinetics (fast or slow opening/closing),
have different ion conductance (large or small ion flow) and have distinct ion-
selectivity stringency (some allow more that one ion type through the pore). It is the
combination of different ion channels present in neurons and other cells what
generates the large diversity and uniqueness of electrical signals and firing patterns
observed in the different cell types (Hille, 1992). 
In recent years it has become evident that of all voltage-gated ion channels
families, the potassium channel family is the largest and most diverse, giving rise to a
myriad of roles in the regulation of the electrical excitability of a cell. In neurons,
potassium channels have been shown to be involved in controlling the cell resting
potential, shape and control action potential duration and frequency, and modulate the
efficacy and frequency of neurotransmitter release. Structurally, most potassium
channels are formed by an assembly of individual protein subunits defined by at least
two transmembrane segments necessary for completing the pore-forming core. The
ability of related subunits to mix and form homomeric or heteromeric channels
provides additional diversity of function (Hille, 1992).
Cloning and genome projects have revealed numerous genes that encode for
potassium channel subunits. Over 80 related potassium channel genes are found in
mammalian systems, 90 in worms and approximately 30 in flies (Hille, 1992;
Littleton and Ganetzky, 2000; Wei et al., 1996), with a surprisingly high degree of
conservation between species. Studies of the mutations in potassium channel genes,
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especially in the genetically malleable flies and worms, have revealed the importance
of the regulation of the expression patterns of these genes in regulating membrane
excitability in different tissues, cell types, and stages of development. Changes in
gene expression that alter the density or ratios of channels can have a strong effect on
cellular electrical properties, suggesting that the large repertoire of channel genes is
not only essential for shaping the electrical characteristics of particular excitable cells
but might be also be important in providing dynamic control of the modulation of
excitability in response to the environment (Levitan and Takimoto, 1998). 
Regulation of excitability as a mechanism for neural homeostasis
Throughout life, neurons are subject to a number of developmental and
environmental perturbations that can alter excitability. In recent years it has become
evident that neurons have the capacity to respond to the perturbations in synaptic
activity, electrical excitability or other neural function in order to maintain their duty
within a reasonable physiological range. The mechanisms that mediate the
maintenance of neuronal functional properties are by definition homeostatic (Davis
and Bezprozvanny, 2001).
The term homeostasis (from Greek: to remain the same) was coined in the
1930's by American physiologist Walter Cannon to describe the capacity of the body
to efficiently regulate its internal environment to maintain a stable physiological
equilibrium. This extraordinary property of living organisms has intrigued
physiologists for many years and has been revealed in a wide range of systems
including cellular responses such as to the changes in extracellular osmolarity, and
system-wide responses like the regulation of blood pressure (Hohmann, 2002;
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Dampney et al., 2002). In the nervous system, homeostatic mechanisms sensitive to
absolute levels of membrane depolarization could be used to set reasonable
physiological limits beyond which changes in neural activity are not tolerated and
prevent neurons from firing excessively or become unresponsive (Davis and
Bezprozvanny, 2001).
Since the intrinsic excitability of the nervous system is determined by the
combination of ion channels expressed in neurons, regulation of ion channel density
has been proposed as a homeostatic mechanism by which neurons can globally
modify their activity without interfering with synapse-specific mechanisms of
plasticity like long-term potentiation and long-term depression (Turrigiano, 1999;
Marder et al., 1996).
Several studies have reported evidence of the modulation of voltage-gated
ionic currents in response to long lasting changes in neural activity. In Drosophila
studies, blocking synaptic activity by expression of tetanus toxin light chain or
mutations that reduce the neurotransmitter acetylcholine, results in an increase in
voltage-gated inward Na+ and outward K+ currents that promotes neural excitability
(Baines et al., 2001). In another study of stomatogastric neurons of crustacea,
transition from tonic to bursting activity have been shown to involve an up-regulation
of inward Ca2+ conductance and a down-regulation of outward K+ conductances
(Turrigiano et al., 1995), while in cultured cortical pyramidal neurons, depriving
activity for two days increases sensitivity to current injection by selectively regulating
voltage-dependent conductances (Desai et al., 1999).
Concordantly, other studies have shown that changes in the expression of
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voltage-gated ion channels result in significant modifications in the electrical
properties of neurons. For example in Aplysia, over-expression of an A-type
potassium channel exerts a substantial shortening of action potential duration,
enhances its hyperpolarizing afterpotential, and depresses the amount of transmitter
release, whereas expression of a non-inactivating potassium channel driven by a rat
heat shock promoter increases the resting potential of Aplysia silent neurons (Kaang
et al., 1992; Han et al., 1999). Meanwhile in Drosophila, increase in ion channel gene
dosage by a duplication of the sodium channel gene para significantly affects the
excitability properties of neurons manifested as an increase in amplitude and duration
of excitatory junction potentials (Stern et al., 1990). Additionally, a study in
developing inferior colliculus neurons shows that depolarization selectively increases
the expression of the Kv3.1 potassium channel resulting in an increase in the
amplitude of a high-threshold, noninactivating current (Liu and Kaczmarek, 1998).
Altogether, this evidence suggests that the regulation of expression of voltage-
gated ion channels genes is critically important for mediating long-term homeostatic
changes to maintain the excitability of the nervous system.
Volatile solvents alter neural excitability
Many drugs have been shown to produce significant alterations in the activity
of the nervous system causing severe physiological and behavioral effects. Based on
their specific effects on neural function, these drugs can be classified into two general
classes. One group is composed of the "sedative-hypnotic drugs" that depress brain
function, and include barbiturates, benzodiazepines and volatile solvents, like ethanol,
inhalants and general anesthetics. The second group is composed of the
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"psicostimulants" that stimulate brain function and include cocaine, amphetamines,
caffeine and nicotine (Julien, 2004).
Of all these drugs, the neural depressants and in particular the volatile
solvents, present the major intrigue as their mode of action has been shown to
compromise a large variety of neural targets and at the same time elicit a wide range
of behavioral and physiological responses that range from hyperactivity to profound
sedation. Low or moderate exposure to volatile solvents can have excitatory effects,
while higher levels of exposure produce sedation and anesthesia. The states of
euphoria, dis-inhibition and drowsiness associated with solvent inhalation has led to
their use as abused drugs in some cases (Dinwiddie, 1994; Flanagan and Ives, 1994),
while the states of sedation, unconsciousness and sleep induced by volatile anesthetic
has led to their use a valuable clinical tools (Meiser and Laubenthal, 2005).
Increasing evidence suggests that volatile anesthetics such as chloroform,
halothane or enflurane suppress neural function through interactions with voltage- and
ligand-gated ion channels (Yamakura et al., 2001; Harris et al., 1995; Shiraishi and
Harris, 2004; Duch et al., 1998; Urban and Friederich, 1998). Many abused volatile
organic compounds including ethanol share these properties and are thought to induce
similar effects to those of volatile anesthetics (Evans and Balster, 1991; Tegeris and
Balster, 1994). In general, the mechanisms of action of volatile solvents is mediated
by the inhibition of excitatory ligand-gated ion channels permeable to Ca2+ and other
cations that tend to depolarize and bring the cell to its firing threshold, and by the
potentiation of inhibitory ligand-gated ion channels permeable to small anions which
cause hyperpolarization of the cell and prevent firing. The combination of these
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effects results in significant depression of the nervous system. 
Amongst the most common excitatory ligand-gated cation channels inhibited
by solvents one finds the nicotinic acetylcholine (nACh) and N-methyl-D-aspartate
(NMDA)-selective glutamate receptors, while the predominant inhibitory ligand-
gated anion channels potentiated by solvents are the gamma-aminobutiric acid type A
(GABAA) and the glycine receptors. Additionally, some volatile solvents have also
been shown to distinctively affect several other ion channels such as the voltage-gated
sodium and potassium channels and the ligand-gated alpha-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid (AMPA) and 5-hydroxytryptamine3 (5-HT3) ion
channel receptors. The slight difference in protein targets affected by the various
solvents is thought to explain some of the differences in the physiological and
behavioral responses elicited by these drugs.
Drug tolerance
Based on the alterations in neural excitability resulting from exposure to these
drugs, it is expected that changes in activity trigger homeostatic mechanisms that
attempt to restore normal neural excitability. Evidence of homeostatic neural
adaptations to drug that affect the nervous system is probably manifested in the form
of tolerance to these drugs. 
A widespread interpretation of drug tolerance is that sustained or repeated
exposure to a drug triggers multiple adaptive mechanisms that reduce the effects of a
particular drug dose. In many cases, these adaptive processes lead to the need for an
increased dose to produce effects of a given magnitude and may also result in the
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physiological manifestations of dependence and withdrawal symptoms that underlie
addiction.
However, tolerance to a specific drug can be manifested in many different
forms depending on the dose, frequency, and duration of administration. Generally, a
decrease in sensitivity that develops during the course of a single drug exposure is
termed acute tolerance, whereas an acquired decrease in sensitivity to the effect of a
drug that results from repetitive exposure to that drug is termed chronic tolerance.
Rapid tolerance describes a form of chronic tolerance that develops after a single
prior exposure to the drug (Young and Goudie, 1995).
Additionally, different models have been suggested for the mechanisms
underlying the different forms of tolerance. A distinction is often made between
tolerance that results from increased metabolic clearance of a drug, which reduces the
concentration of a drug or its duration of action in a target system (pharmacokinetic
tolerance) and tolerance that results from cellular-adaptive mechanisms that reduce
the sensitivity of drug-sensitive systems to a given drug concentration
(pharmacodynamic or functional tolerance). Homeostatic neural adaptations triggered
by the effects of a drug are thought to be a mechanism of functional tolerance (Young
and Goudie, 1995).
Because the electrical character of a neuron is an emergent property of the
channels that it expresses, likely regulators of these homeostatic changes are ion
channel proteins and genes. Changes in gene expression that alter the density or ratios
of channels can have a strong effect on cellular electrical properties and could thus
contribute to drug tolerance. However, whether the expression of voltage-gated ion
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channel genes is modulated by volatile solvents or if tolerance can arise from long-
term changes in excitability caused by changes in voltage-gated ion channel gene
expression remains unknown. 
Dissertation Overview
The overall goal of this study is to investigate the role that the modulation of
voltage gated-ion channel gene expression plays in the homeostatic regulation of
neural excitability that results in tolerance to sedative drugs. For this purposes, I have
used a candidate gene approach in the Drosophila melanogaster model system.
Chapters 2 and 3 investigate the effects of volatile solvents on the expression
of a candidate voltage-gated ion channel genes and whether the changes in expression
play a role in the development of functional tolerance to these drugs. Chapter 2
explores the changes in expression of the calcium-activated, voltage-gated potassium
channel gene slowpoke in response to alterations in neural excitability, while by using
gene mutations and inducible transgenes, chapter 3 investigates the role that
transcriptional changes in the slowpoke gene play in the development of tolerance to
sedation. Although the study focuses on the effects of volatile solvents, a survey of
the effects of different agents and treatment that induce changes in excitability has
also been conducted to further explore the nature behind the changes observed.
Most of the data presented in chapters 2 and 3 was published in an article in
the Proceedings of the National Academy of Sciences in December 2004 (Ghezzi et
al., 2004) and are reprinted with the copyright permission policy of The National
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Academy of Sciences. © 1993-2005 by The National Academy of Sciences of the
United States of America.
Chapter 4 presents data that investigates the role that four other voltage-gated
ion channel genes found in Drosophila play in the development of tolerance to
sedation. The genes tested encode the seizure and Shaker potassium channels, the
para sodium channel and the cacophony calcium channel. Additionally, this chapter
offers further analysis of the role that two Drosophila signal transduction pathways
that modulate activity-dependent changes in gene expression play in tolerance to
sedation. 
Chapter 5 presents an electrophysiological analysis of the role of the
transcriptional regulation of the slowpoke gene in modulating neural activity in
Drosophila. Additionally, a correlation between the long-term electrophysiological
effects of solvent sedation and changes in channel gene expression are presented.
An extensive discussion of the results and further literature review is
presented in the Discussion section of each chapter (chapters 2 to 5). Detailed
descriptions of the methods used are also presented at the end of each chapter.
Finally, chapter 6 presents a summary of the results obtained along with the
conclusions derived.
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Chapter 2: Effects of Sedation on Ion Channel Gene Expression
Introduction
Many organic solvents including ethanol and volatile anesthetics cause
dramatic changes in neural excitability. Moderate exposure can have excitatory
effects, while higher levels of exposure produce sedation and anesthesia. The
euphoria and intoxication associated with solvent inhalation has led to their use as
abused drugs (Dinwiddie, 1994; Flanagan and Ives, 1994).
The changes in neural activity caused by exposure to these drugs may trigger
homeostatic mechanisms that attempt to restore normal neural excitability. Because
the electrical character of a neuron is an emergent property of the channels that it
expresses, a likely target of these homeostatic changes are ion channel proteins and
genes. Changes in gene expression that alter the density or ratios of channels can have
a strong effect on cellular electrical properties (Levitan and Takimoto, 1998) and, in
the case of drug-induced changes in excitability, could contribute to drug tolerance
and addiction.
The slowpoke gene encodes a BK-type Ca2+ -activated, voltage-gated K+
channel. This channel integrates two of the most basic methods of neural signaling: it
responds both to increases in free Ca2+ and to changes in membrane potential. Null
mutations in the slowpoke gene cause subtle changes in fly behavior. Drosophila
lacking slowpoke expression have a reduced capacity for flight, show a stimulus-
induced “sticky-feet” phenotype, have an unusual mating song, are arrhythmic with
regard to circadian rhythms and are more sensitive to sedation by volatile anesthetics
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(Atkinson et al., 2000; Ceriani et al., 2002; Leibovitch et al., 1995; Peixoto and Hall,
1998). In C. elegans, the channel encoded by the slowpoke homologue is directly
modulated by ethanol and genetic studies have shown that it plays a role in the
mechanism of intoxication (Davies et al., 2003).
In flies, the slowpoke gene is expressed in neurons, muscles, midgut, and
trachea and has a very complex transcriptional control region (Becker et al., 1995).
Expression of slowpoke has been shown to be controlled by five tissue-specific
promoters which finely determine expression in the different tissues along
development (Bohm et al., 2000; Brenner et al., 1996).
In this chapter, I use Drosophila and the channel gene slowpoke to study the
changes that occur at the transcriptional level in the nervous system in response to
alterations in neural excitability. Although this study focuses on the effects of volatile
solvents, a survey of the effects of different agents and treatment that induce changes




Volatile solvents alter excitability in Drosophila
Four different volatile solvents with known effects on behavioral and
neurological excitability in mammals were tested in Drosophila. These are: benzyl
alcohol, chloroform, toluene and trichloroethylene. Benzyl alcohol is well-known for
its properties as a local-anesthetic (Wilson and Martin, 1999; Nuttall et al., 1993)
while chloroform is a popular volatile anesthetic widely used the late 19th and early
20th centuries (Wawersik, 1997). Toluene and trichloroethylene on the other hand,
are volatile organic compounds commonly used as industrial solvents for glues, paint
thinners, degreasing agents, and dry-cleaning agents. When misused, exposure to
sufficient concentrations of these compounds results in a range of behavioral
disturbances including euphoria and sedation (Flanagan and Ives, 1994; Evangelista
and Duffard, 1996). Following is a description of the behavioral effects induced in
flies by exposure to each of these solvents. 
Benzyl alcohol
Exposure to benzyl alcohol was performed by coating the walls of a 30 ml
glass tube with 200 ul of a benzyl alcohol solution in acetone of three different
concentrations (0.15%, 0.3% and 0.4%) and a 100% acetone control. The more
volatile acetone was then allowed to evaporate as the tubes were continuously rotated
in a rotating wheel leaving a thin coat of evenly distributed benzyl alcohol. As flies
are placed in the tubes and exposed to the solvent, they rapidly became hyperexcited,
and were observed spinning and shaking followed by a period of deep sedation with
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no signs of movement or trembling of the legs or wings. 
On average, the hyperactive phase appeared at approximately one minute after
insertions of flies into the coated tube. Although, initially this was manifested as
increased locomotion, this behavior steadily progressed for the next 5 minutes to
uncoordinated jumps and spins. After this time, flies dropped to the bottom of the
tube, laid on their backs and were unable to right them self up, but were still able to
show movement of the limbs (mainly shaking). By the 10th minute, all movement
stopped completely. At this point, flies were removed from the benzyl alcohol coated
tube and transferred to a clean glass tube. 
All the three doses were sub lethal and flies returned to normal behavior after
a recovery period. Although the duration of the hyperactive phase did not changed
with the different doses, the sedative phase became significantly longer as the dose of
benzyl alcohol increased. Flies that were treated with the lowest concentration of
benzyl alcohol (0.15%) started recovery within the first two minutes, while flies
treated with 0.3% or 0.4% benzyl alcohol remained sedated for approximately 10 and
20 minutes respectively. Recovery was indicated by the return of a natural standing
posture. In most cases, individual flies resume normal behavior a few seconds after
recovery, characterized by the typical exploratory behavior and climbing of the walls
of the tube, a few seconds after recovery. 
Chloroform
Since chloroform is significantly more volatile than benzyl alcohol, exposure
to this solvent was performed differently. Flies were exposed to the chloroform by
inverting a glass tube containing flies over a small centrifuge tube containing 500 ml
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100% chloroform at room temperature. A porous piece of paper tissue was used to
secure the flies in the tube and prevent them from falling into the solvent. No
noticeable effect was observed during the first 10 minutes of exposure to the fumes.
After this time, flies started falling to the paper barrier at the bottom of the tube with
no signs of hyperactivity. Flies laid on their backs, and were completely sedated.
After all flies were knocked down (20 minutes) the tube containing chloroform was
removed and flies were allowed to recover. With this treatment, flies remained
sedated for at least 10 minutes, after which the first flies started to recover. It took
approximately 10 more minutes for the rest of the population to recover fully.
However, in almost every case, a small percentage of flies (<10%) never recovered.
As with benzyl alcohol, recovery was indicated by the return of a natural standing
posture.
Toluene
Flies were exposed to toluene in the same way as to chloroform. As with
chloroform no noticeable effect was observed during the initial minutes of exposure
to the fumes. In this treatment, effects were evident at around 8 minutes. With this
solvent however, a very different effect was observed. A pronounced state of
hyperactivity that resembled the effect induced by the initial phase of benzyl alcohol
exposure was noticed. Mainly, flies were observed spinning and shaking for at least
20 minutes. After this time flies some flies stopped moving and gave the impression
of being dead as indicated by a characteristic positioning of the wings (snapped back)
that dead flies usually display. Indeed, this flies never recovered after removal of the
solvent.
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In a second trial, the same procedure was repeated, but this time, the tube
containing toluene was removed 12 minutes after the hyperactive effects initiated. In
this trial, flies did not die nor became sedated. The hyperactivity ceased within 2
minutes.
Trichloroethylene
Trichloroethylene exposure was performed in a similar way to toluene. The
effects observed were also very similar to toluene exposure, but not as lethal. Again,
the solvent was removed after the first 12 minutes of hyperactivity and flies returned
to normal behavior.
Benzyl alcohol intoxication increases slowpoke mRNA abundance
In spite of the fact that all solvents used induced clear changes in the
excitability of the fly's behavior only benzyl alcohol exposure allowed an easy way to
control the dose used. Additionally, it was the solvent with the lowest morbidity rates.
For these reasons it was chosen to determine if altered neural excitability would cause
changes in slowpoke gene expression in a dose dependent manner.
To investigated changes in expression caused by exposure to benzyl alcohol,
slowpoke messenger RNA abundance was measured. Total RNA was extracted from
treated flies six hours after solvent exposure, to allow time for changes in gene
expression to occur. The level of slowpoke mRNA in the nervous system was
determined using real-time RT-PCR to quantify the neural-specific slowpoke exon
called C1 (Brenner et al., 1996). 
For this method, total RNA is reverse transcribed using gene specific primers
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for C1. The resulting cDNA was then amplified by PCR in the presence of gene
specific dual-labeled single stranded probes for C1. As the cDNAs are amplified at
each PCR cycle, the dual-labeled probes are destroyed and fluorescence is emitted in
a manner proportional to the quantity of the amplified product.
To account for variability in purification efficiency, the abundance of
slowpoke mRNA was normalized and expressed relative to the abundance of mRNA
from the Cyclophilin 1 gene. Cyclophilin 1 mRNA was chosen as an internal control
because its abundance was not affected by the experimental paradigm (Figure 2.1B).
The validity of this control was confirmed by demonstrating that normalization
against total RNA yielded a slowpoke expression profile that was essentially the same
as that obtained using the Cyclophilin internal control. 
Following a single 15 minute exposure to three different doses of benzyl
alcohol a dose-dependent change in the abundance of slowpoke mRNA was observed
(Figure 2.1A). The intermediate dose (0.3%), which produced a 53% change in
slowpoke message abundance, was chosen for subsequent experiments because it had









































































Figure 2.1: Effects of benzyl alcohol on slowpoke mRNA levels. Flies
were placed in glass vials whose walls were coated with 200 ul of a 0.15%
0.3% or 0.4% benzyl alcohol solution. Sedated flies were allowed to recover
for 6 hours and then the abundance of slowpoke and Cyclophilin transcripts
were measured. A) A dose-dependent benzyl alcohol-induced increase in
slowpoke mRNA level as measured by real-time PCR is observed. The
abundance of slowpoke message was expressed relative to the Cyclophilin
internal control. The abscissa shows normalized slowpoke mRNA levels
relative to control animals (No BA) that were not exposed to benzyl alcohol
but were otherwise treated identically. B) Validation of the Cyclophilin
internal control. The abundance of the slowpoke and Cyclophilin 1 (Cyp1)
messages from untreated flies (black bars) or treated with 0.3% benzyl alcohol
(white bars) was normalized to total RNA and expressed relative to control
animals (untreated). Error bars show standard error of the mean. (*) indicates
significant difference from control (P < 0.01).
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Increase in slowpoke mRNA abundance occurs through transcriptional 
activation of neural promoters
The benzyl alcohol-induced increase in slowpoke mRNA could arise from the
two different situations. One, in which transcription from the slowpoke gene has been
activated, leading to the production of new transcripts, and another in which the
stability of existing slowpoke mRNA is increase, preventing normal degradation of
the transcripts.
To determine if the increase in slowpoke mRNA abundance arises from
transcriptional activation of the gene or from changes in mRNA stability, a transgenic
line of flies carrying the P3 reporter-gene construct (figure 2.2A) was used. This
construct contains the portion of the slowpoke transcriptional control region
responsible for neural expression, including promoters/exons CO and C1, driving
expression of the β-galactosidase reporter gene. Since flies do not naturally express
the β-galactosidase gene, one can detect transcriptional activation of the slowpoke
neural promoters by assaying for β-galactosidase activity. In fact, it has been
demonstrated that expression from this construct reproduces the neural expression
pattern of slowpoke (Bohm et al., 2000; Brenner et al., 1996; Thomas et al., 1997). 
To test if the slowpoke neural promoter is activated by benzyl alcohol, the
response of the P3 β-galactosidase reporter transgene was measured in treated and
control P3 flies. The endogenous slowpoke gene and the reporter gene share the same
transcriptional control regions, however they express distinct transcripts whose
stability is unlikely to be co-regulated. Therefore, a coincident increase in slowpoke
mRNA and in slowpoke driven β-galactosidase expression is likely to reflect an
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increase in promoter activity rather than a change in mRNA stability. P3 flies treated
with benzyl alcohol showed a 41.5% increase in β-galactosidase specific activity 11
to 14 hours after treatment, relative to untreated flies (Fig. 2.2B). The increased
incubation time, with regard to the previous experiment, was included to ensure
enough time for translation of the reporter. This response is similar to the change
observed in mRNA abundance from the endogenous gene. Therefore, the benzyl
alcohol-induced boost in expression is largely or completely attributable to a change



































No BA 0.3% BA
Figure 2.2: Benzyl alcohol-induced increase in slowpoke transcriptional
activity. Five to seven day old transgenic flies carrying a transgene composed
of the slowpoke neuronal promoter upstream of the β-galactosidase gene were
placed in glass vials whose walls were coated with 200 ul of a 0.3% benzyl
alcohol solution. Sedated flies were allowed to recover for 11 to 14 hours and
then transcriptional activity of the transgenic slowpoke promoter was
determined by measuring β-galactosidase specific activity. (A) Map of the P3
transgenic construct in which the slowpoke neural promoter drives expression
of the β-galactosidase gene. (B) Effects of benzyl alcohol on transcription
from the P3 transgene as measured by β-galactosidase specific activity (BA).
β-galactosidase specific activity was normalized to total protein and expressed
as to untreated control animals (No BA) that were not exposed to solvent but
were otherwise treated identically. Error bars show standard error of the mean.
(*) indicates significant difference from control (P < 0.01).
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Increased slowpoke expression is a response to sedation
Considering the important role of slowpoke in regulating electrical excitability
in neurons, it seems reasonable to believe that the observed increase in slowpoke
expression after benzyl alcohol, a solvent anesthetic that dramatically affects the
activity of the nervous system, is a compensatory mechanism that responds to the
changes in activity rather than to the solvent it self. However, when exposed to an
incapacitating dose of benzyl alcohol, flies pass through a hyperkinetic phase before
entering the sedative phase. Thus, the induction of slowpoke could be a response to
either hyperactivity or sedation. A variety of drugs, temperature treatments and
excitability mutants with different effects on the activity of the nervous system were
used to determine if the increase in slowpoke mRNA is a response to the hyperactive
or the sedative phase.
To examine the effect of hyperactivity on slowpoke mRNA abundance,
genetic and environmental methods were used. First, ion channel mutations were used
to produce animals that were genetically hyperactive. In Drosophila, alterations in
gene dosage by mutations that target ion channels directly affect the
electrophysiological properties of the nervous system and result in altered behaviors.
The mutations used were seits1, Hk1, eag1Sh120b double mutant and Dp-para (Ganetzky
and Wu, 1983; Jackson et al., 1985; Kamb et al., 1988; Stern and Ganetzky, 1989;
Stern et al., 1990). The first three are mutations in voltage-gated K+ channel genes or
K+ channel accessory subunits and produce hyperexcitability by perturbing K+
channel activity. The fifth mutation (Dp para) is a duplication of the para Na+
channel gene and is believed to produce hyperexcitability by increasing the
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production of para voltage-gated Na+ channels. The mRNA abundance of slowpoke
in these mutants was determined using the real-time PCR method described
previously. In all of these animals slowpoke mRNA abundance is reduced with
respect to the wild type (Figure 2.3A).
Hyperexcitability without sedation was also environmentally induced. As
described previously, in flies, toluene and trichloroethylene, except at extremely high
doses, produced only a hyperkinetic response. Additionally, when flies are exposed to
a low dose of benzyl alcohol but are removed from the solvent before they become
sedated, they show only hyperkinesis. Elevated temperature (37oC) also causes flies to
move more rapidly (Gibert et al., 2001) and was also used to produce populations of
hyperkinetic flies. Levels of mRNA were measure 6 hours after each treatment. Each
treatment reduced the abundance of slowpoke mRNA (Figure 2.3A).
Conversely, sedation without hyperactivity was also induced. Chloroform
which as described previously causes sedation, as well as CO2 and cold anesthesia
(0oC), two common forms to induce sedation in flies (Xia et al., 1999; Seiger and
Kink, 1993), were used. Additionally, the sodium channel blocker tetrodotoxin
(TTX), was applied by injecting flies with a sublethal dose that causes paralysis. Each









































































A TOL TCE BA# Heat
Figure 2.3: slowpoke gene expression and activity levels are inversely
related. slowpoke transcript abundance relative to Cyclophilin 1 as measured
by real-time RT-PCR from mutant flies and flies exposed to drugs that induce
hyperactivity (gray bars) or sedation (black bars). A) Relative slowpoke
expression in the hyperexcitable mutants eag1Sh120b , seits1, Hk1, and Dp-para
and in animals treated with toluene (TOL), trichloroethylene (TCE), 0.3%
benzyl alcohol (BA#-flies were removed from the benzyl alcohol before
entering anesthesia), and 37°C heat shock (Heat). B) Relative slowpoke
expression levels, six hours after sedation with chloroform (CHCl3), carbon
dioxide (CO2) or 0°C cold anesthesia (Cold). C) Relative slowpoke expression
levels, six hours after tetrodotoxin (TTX) injection. All values are
significantly different from control (p < 0.01)
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Effects of sedation on slowpoke expression are neural-specific and may involve 
the transcription factor CREB
In order to test if the effects on slowpoke expression are tissue specific, I
examined the effects of benzyl alcohol and toluene on the mRNA of a muscle-specific
isoform of slowpoke. 
Total RNA was extracted from treated flies six hours after solvent exposure,
to allow time for changes in gene expression to occur. The level of slowpoke mRNA
in muscles was determined using real-time RT-PCR to quantify the muscle-specific
slowpoke exon called C2 (Brenner et al., 1996). No significant change was observed
in slowpoke muscle mRNA levels following a single 15 minute exposure to benzyl
alcohol or toluene (Figure 2.4A). 
Finally, the effects of benzyl alcohol- and toluene-induced changes in activity
were also tested on the mRNA levels of the transcription factor CREB. This
transcription factor whose name stand for cAMP responsive element binding protein,
has been implicated as underlying some of the long-lasting changes in neural gene
expression following drug exposure (Chao and Nestler, 2004; McClung and Nestler,
2003). In Drosophila, the dCrebA gene encodes the d-CREB-A protein, one of the
two CREB-type transcription factor genes found in flies. Following a single 15
minute exposure to a dose of 0.4% benzyl alcohol a change in the abundance of
dCrebA mRNA was observed. On the other hand, exposure to toluene did not cause a
significant change in dCrebA (Figure 2.4B), suggesting that up-regulation from this












































































Figure 2.4: Effects of solvents on the expression levels of a muscle-
specific slowpoke transcript and the dCrebA gene. A) The mRNA abundance
of a muscle slowpoke isoform was measured relative to Cyclophilin 1 by real-
time RT-PCR from wild type flies that were treated with either 0.4% benzyl
alcohol (BA), toluene or were left untreated (Control). The abscissa shows
normalized mRNA levels from the slowpoke muscle C2 exon relative to
control animals that were not exposed to solvents but were otherwise treated
identically. B) The mRNA abundance of the dCrebA gene was measured
relative to Cyclophilin 1 by real-time RT-PCR from wild type flies that were
treated with either 0.4% benzyl alcohol (BA), toluene or left untreated
(Control). The abscissa shows normalized mRNA levels from dCrebA relative
to control animals that were not exposed to solvents but were otherwise
treated identically. Error bars show standard error of the mean. (*) indicates
significant difference from control (P < 0.01).
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Discussion
Increasing evidence suggests that volatile anesthetics suppress neural function
through interactions with voltage- and ligand-gated ion channels (Yamakura et al.,
2001) (Harris et al., 1995; Shiraishi and Harris, 2004; Duch et al., 1998; Urban and
Friederich, 1998). Many volatile organic compounds including those studied here,
share this properties and are though to induce similar effects to those of volatile
anesthetics (Evans and Balster, 1991; Tegeris and Balster, 1994). Specifically, the
organic solvent benzyl alcohol has been shown to be an effective blocker of sodium
channels (Haeseler et al., 2000; Elliott et al., 1987), potassium channels, (Elliott and
Elliott, 1997) and nicotinic acetylcholine receptors channels (Bouzat and Barrantes,
1991). Chloroform has been shown to potentiate GABAA and glycine receptors
(Beckstead et al., 2001; Beckstead et al., 2000) as well as to activate two-Pore-
domain K+ channels (Patel et al., 1999). Additionally, effects of toluene and
trichloroethylene were shown to potentiate GABAA and glycine receptors (Beckstead
et al., 2001; Beckstead et al., 2000), enhance serotonin-3 receptor function (Lopreato
et al., 2003) inhibit NMDA (Cruz et al., 1998) and nicotinic acetylcholine receptors
(Bale et al., 2002) and more recently, effects of toluene and trichloroethylene were
demonstrated to affect voltage-sensitive Ca2+ channel function (Shafer et al., 2005).
Although the molecular targets affected by these compounds may help explain
their sedative properties, here we have observed that in Drosophila exposure to this
solvents can cause a series of excitation states that range from just sedation
(chloroform), just hyperactivity (toluene and trichloroethylene) or a biphasic
response represented as a initial hyperactive stated followed by a sedative state
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(benzyl alcohol). Interestingly, these opposing responses have also been noted in
mice when exposed to different doses of volatile organic solvents, with lower doses
corresponding to states of hyperactivity and high doses correlated to the sedative
phase (Bushnell et al., 1985). Presumably, the different behavioral responses arises
from independent effects of different concentrations on the various ion channel
targets. 
In the solvent exposure protocols used in this study, the doses used for toluene
and trichloroethylene were not sufficient to induce sedation and were limited to a
state of hyperactivity. Unfortunately, higher doses attempted with longer exposure
times resulted in lethality. On the other hand, the dose used for chloroform induced
just the sedative phase with no hyperactivity. A shorter exposure to chloroform will
result in no detectable effect. 
This results are not entirely surprising since many volatile solvents, especially
those use for anesthesia have dose response curve that become extremely steep
around doses that induce behaviors that reflect an anesthetized state (Eger et al.,
2001). Therefore, in order to generate a complete survey of the different behaviors
elicited by the solvents over a range of concentrations, it will require a fine control
over the delivery concentrations of the volatilized solvents. Such control usually
requires expensive vaporizers used for clinical anesthesia that were not available in
the lab. 
Only the low volatility of benzyl alcohol permitted control over the dose,
without the need for increased exposure time or for a sophisticated anesthetic
machine, to elicit the full range of a characteristic biphasic response. Fortunately, the
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slight difference in vapor pressure of chloroform and toluene (or trichloroethylene)
elicit opposing behaviors in the present Drosophila study using the same crude
delivery methodology. 
In this study it was hypothesized that the changes in neural excitability caused
by these agents will trigger adaptive mechanisms to counter these effects. One
possible way for such adaptation may involve the transcriptional regulation of genes
involved in the modulation of neural excitability such as ion channel genes. One such
gene is slowpoke, which encodes the calcium activated potassium channel. 
The response in expression of slowpoke after exposure to benzyl alcohol is
dose dependent. Interestingly, with the different doses of benzyl alcohol, the duration
of the hyperactive phase was not changed, while the sedative phase was significantly
prolonged as the dose increased. Therefore, the increasing trend of slowpoke
expression with the dose is presumed to be in response to the increased duration of
sedation. 
In accordance with this observations, slowpoke gene expression responded
differently to the solvents with opposing effects on behavioral activity. In other
words, increased transcription is observed after exposure to the sedation by
chloroform while a reduction in expression results from exposure to the hyperactivity
induced by toluene and trichloroethylene. Consistently, even unrelated treatments that
result in comparable behaviors; such as temperature shocks (heat or cold), gaseous
compounds (CO2), or even toxins and mutations that target ion channels; resulted in
expression profiles that corresponded to the particular behavior elicited by treatment.
This evidence thus points toward a non-specific regulation of slowpoke expression in
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response to activity rather to a specific drug or drug class. 
Activity-Dependent regulation of gene expression has previously been
identified in the nervous system and is though to be part of a critically important
mechanism to compensate or potentiate sudden changes in neural activity. Most
studies have focused on the regulation of immediate early genes (IEGs) and the
requirement for the cAMP/Ca2+ responsive element binding protein CREB, a
transcription factor shown to mediate long-term synaptic plasticity mechanisms
(Huang et al., 1994; Sheng and Greenberg, 1990; Bito et al., 1996; Etter et al., 2005).
However, output target genes directly involved in the modulation of the electrical
properties of neurons are still largely unknown. 
Considering that potassium channels exert direct control of the resting
membrane potentials of excitable cells like neurons (Hille, 1992), this class of
proteins represent reasonable candidates to mediate synaptic plasticity mechanisms
that may underlie homeostatic adaptations to the experience-dependent changes in
neural activity. Furthermore, many of the transcriptional control regions of potassium
channels include the cAMP responsive element (CRE), binding motif for the
transcription factor CREB, and have been shown to be up-regulated by cAMP (Mori
et al., 1993; Gan et al., 1996; Yao et al., 1996), evidence that further support the
candidacy of potassium channels for mediating synaptic plasticity mechanisms
specifically through transcriptional activation.
Data presented here clearly suggests that the changes in expression of the
large-conductance voltage and Ca2+ -dependant K+ channel encoded by slowpoke may
be part of a homeostatic response that attempts to resist the changes in neural activity
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caused by the various treatments (Further discussion of the role of slowpoke up-
regulation in molding neural activity is presented in chapters 3 and 5). Not
surprisingly, the changes in slowpoke are neural specific, and do not involve
regulation of muscle expression. In Drosophila, expression of slowpoke in different
tissues is controlled by multiple regulatory elements thus expression in one tissue can
be regulated independently from the others (Brenner et al., 1996; Brenner and
Atkinson, 1996). Furthermore, the Drosophila slowpoke transcriptional control region
contains at least two canonical CRE sequences, 5'TGACGTCA3', in regions that
have been shown to control tissue specific expression (unpublished data). 
Although, CREB activity associated with the transcriptional activation of CRE
regulated genes is modulated by phosphorylation of specific sites in the CREB protein
(Gonzalez and Montminy, 1989; Sheng et al., 1990), in Drosophila a CRE binding
site is also found 61 bp upstream from the 5'-most start of dCrebA suggesting that,
like a number of other transcription factors, dCREB-A may autoregulate in-vivo
(Rose et al., 1997). Therefore, a coincident increase of dCrebA and slowpoke mRNAs
after benzyl alcohol sedation suggests that the activity dependent regulation of
slowpoke might be mediated by the activation of dCREB-A that precedes binding of
CRE sites within the slowpoke and dCrebA transcriptional regulation regions. 
CREB mediated regulation of slowpoke is a very satisfying hypothesis since
it's activation is mediated by numerous signaling pathways that may be triggered by
changes in neural excitability including protein kinase A (PKA), protein kinase C
(PKC) and calcium-calmodulin (CaM) kinase II (Gonzalez et al., 1989). Interestingly,
toluene exposure, which causes hyperactivity in flies and a decrease in slowpoke
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expression, did not cause a change in dCrebA mRNA, suggesting that dCREB-A
may be activated only in response to signaling pathways that result from the
depression and not the enhancement of neural activity and acts as a transcriptional
activator of slowpoke and not as a repressor of transcription. 
One signaling pathway that may account for this observation is the CaM
Kinase II pathway which becomes activated by changes in intracellular calcium
commonly associated with neural activity. In fact, this Drosophila CREB contains
three CaM Kinase II phosphorylation sites but no PKA phosphorylation sites (Smolik
et al., 1992). 
In summary, the evidence suggests that the changes in activity associated with
sedation by volatile solvents and anesthetics result in the up-regulation of the
slowpoke gene presumably from the activation of the transcription factor CREB by a
signaling pathway that senses changes in neural activity. More importantly, these





All flies used in the experiments discussed in this chapter were raised on
standard cornmeal/molasses/agar medium. Flies were kept in a room with constant
temperature (22 oC) and 12:12 hrs light:dark cycles. Flies that emerged from pupae
were collected over a 2-day period, transferred to fresh food, and studied between
three to five days later. In this way, all flies are roughly between five to seven days
old. Different mutants with altered excitability were used. Genotype of mutant stocks
were eag1Sh120b, seits1, hk1 and Dp-para. Transgenic line P3 carrying a reporter gene
construct was used for β-galactosidase experiments. Wild types flies used were
Canton S and w1118 . The w1118 flies were tested because it is the genetic background
for the transgenic stocks used throughout this study. The behavioral and molecular
responses of Canton S and w1118 were not distinguishable.
Pharmacological manipulations
Several chemicals were administered to flies to alter their excitability. The
following solvents and anesthetics were used: acetone, toluene, trichloroethylene,
chloroform, benzyl alcohol (EM Science, Gibbstown, NJ; or Fisher Scientific,
Fairlawn, NJ; or Mallinckrodt Baker inc., Paris, KY), CO2 (Airgas, Radnor, PA), and
cold anesthesia. The administration method varied between different chemicals and
treatments to accommodate for the differences in their physical properties (figure
2.x).  
Exposure to chloroform, toluene, and trichloroethylene was performed by
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inverting a 30 ml glass tube containing approximately 25 flies over 0.5 ml of 100%
solvent in a 1.5 ml microfuge tube. Flies were trapped in the glass tube by plugging
the open end of the tube with a small piece of Kimwipe® (4 cm X 4 cm) wrapped
around the cap of a 15 ml conical tube. The cap had been perforated on the top
(perforation was 1 cm diameter). The cap and Kimwipe® fitted tightly in the tube.
The Kimwipe® is porous enough to let solvent fumes enter the glass tube through the
perforation on the cap. After a 15 minute exposure the flies were transferred to food
for recovery. 
Exposure to benzyl alcohol was performed by coating 30 ml glass vials with
200 ul of a solution of benzyl alcohol in acetone (0.15%, 0.3% or 0.4%). Control
experiments were performed using acetone by itself. The vials were continuously
rotated for 45 minutes at 22°C to evaporate the more volatile acetone until
completion, leaving a evenly distributed thin coat of the less volatile benzyl alcohol.
Approximately, Twenty-five flies were placed in each vial and exposed to the benzyl
alcohol or to the acetone control (evaporated) until all flies in the benzyl alcohol
group were sedated (10 to 15 minutes). After this period, flies were transferred to
food containing vials for recovery.
For CO2 anesthesia, flies were placed in a constant stream of the gas for 15
minutes. Flies were then transferred to food for recovery. Heat and Cold were also
used to induce changes in excitability. Glass vials containing approximately 25 flies
were placed for 15 minutes in ice for cold anesthesia or in a 37°C incubator for heat
shock. In both cases, flies were transferred to food for recovery after treatment. All










































Figure 2.5: Various treatments used to alter excitability in flies. (A)
Treatment with highly volatile solvents (toluene, chloroform,
trichloroethylene). Flies are trapped in a 30 ml glass vial using a piece of
Kimwipe® secured with a perforated cap. The vial is inverted over a
centrifuge tube containing the solvent. (B) Exposure to benzyl alcohol. Glass
vials are coated with 200 ul of a solution of benzyl alcohol in acetone by
rotating the vial at room temperature for 30 to 45 minutes. For exposure, flies
are trapped in the coated vial as in A. (C) Exposure to CO2. Gas is injected at
~10 PSI into a vial containing flies using a needle that perforates the
Kimwipe® that traps flies in the vial. (D) Exposure to cold. Flies are trapped
in the a glass vial as in A. Vial is immersed in ice. (E) Exposure to heat. flies
are trapped in the a glass vial as in A. Vial is placed in a 37oC incubator.
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Finally, the sodium channel blocker tetrodotoxin (TTX) was used to alter
electrical activity in fly brains. Flies were injected in the abdomen with 100 nl of TTX
dissolved in a vehicle solution 0.1M Na2HPO4 and 5mM KCl, pH 6.8. Vehicle alone
was used as a control. Approximately 60 flies were injected with the toxin in a period
of 30 minutes. Flies were transferred to food right after injection and separated in 3
groups of approximately 20 flies each.
RNA extraction
Total RNA was extracted from each group of 20 to 25 flies six hours after the
start of the treatment using a single-step RNA isolation from cultured cells or tissue
protocol (Ausubel, 1994) with some modifications.
Flies were ground in liquid nitrogen into a fine powder and transferred to a
1ml dounce homogenizer containing 1 ml of denaturing solution (4M guanidinium
thiocyanate, 25mM sodium citrate, 0.1M 2-mercaptoethanol, 0.5% sarkosyl) and
homogenized slowly for 2 minutes. 0.5 ml of the homogenate was transferred into a
1.5 ml microfuge tube. 50 ul of 2M sodium acetate, pH 4, 0.5 ml of water-saturated
phenol/chloroform 5:1 pH 4.5 (Ambion Inc. Austin, TX) plus 0.1 ml of a 49:1
chloroform : isoamyl alcohol mixture (each from Fisher Scientific, Fairlawn, NJ)
were added, mixed and incubated for 15 min in ice. The suspension was then
centrifuged for at 4 °C for 15 min in a microcentrifuge at max speed. The upper
aqueous phase containing the RNA was transferred to a fresh 1.5 ml microfuge tube.
The RNA was precipitated by adding 1 volume of 100% isopropanol, followed by
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incubation at –20 °C for 20 minutes and centrifugation for 10 minutes at 10,000xg.
The dried pellet was then washed in 0.5 ml 75% ethanol, vortexed, and incubated for
10 to 15 minutes at room temperature to extract residual guanidinium thiocyanate.
The pellet was centrifuged for 5 min at 10,000Xg and the supernatant discarded. The
pellet was air-dried for 5-10 minutes and resuspended in 0.2 ml DNase buffer, 3 ul of
Superase-In RNase inhibitor and 2 ul of RNase free DNase I (Ambion Inc. Austin,
TX) and incubated for 30 minutes at 37 °C. Subsequently, the sample was extracted
with phenol/chloroform as before followed by an ethanol precipitation. The pellet was
then resuspended in 0.1 ml of DEPC – H 2 O and stored at -80 o C. RNA quality was
determined by electrophoresis in a 1% agarose gel and quantified by fluorometry
using the RiboGreen® RNA quantitation kit (Molecular Probes, Eugene, OR) on a
VersaFluor™ fluorometer system (Bio-Rad, Hercules, CA).
Quantitative real-time RT-PCR
The abundance of neurally expressed slowpoke message was determined by
quantifying abundance of the slowpoke exon C1 relative to a Cyclophilin 1 (Cyp1)
exon using the TaqMan® real-time RT-PCR assay whereas abundance of the muscle
specific slowpoke exon C2 and a dCrebA exon were quantified relative to Cyp1 using
the SYBR Green I nucleic acid stain real-time RT-PCR assay.
First-strand cDNA was synthesized from 100 ng of total RNA, primed with
200 nM each of gene specific primers (0.2 uM) for neural-slowpoke (C1), muscle-
slowpoke, dCrebA and for Cyp1 transcripts with Superscript II reverse transcriptase
(Life Technologies). Each reaction was performed in triplicate (experimental
replicates) from independent RNA samples. Six additional reactions with were
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performed from a dilution series of RNA concentrations (0 ng, 25 ng, 50 ng, 100 ng,
200 ng and 400 ng) produced form an arbitrary RNA sample (usually one of the
control samples) to create a standard curve. The standard curve is used for
quantification purposes and to prove the linearity of the assay.
For experiments involving slowpoke exon C1, the cDNA was amplified by
real-time PCR in an ABI Prism® 7700 Sequence Detection System (Applied
Biosystems) in the presence of gene specific dual-labeled single-stranded probes. The
primers used to detect the slowpoke exon C1 were 5’- aaacaaagctaaataagttgtgaaagga-
3’ and 5’-gatagttgttcgttcttttgaatttga-3’ while the primers 5’-accaaccacaacggcactg-3’
and 5’-tgcttcagctcgaagttctcatc- 3’ were used to detect the Cyp1 message. These
primers flanked the TaqMan oligonucleotide probes 5’-
(FAM)agaaactgcgcttagtcacactgctcatgt(TAMRA)-3’ and 5’-
(FAM)cggcaagtccatctacggcaacaagtt(TAMRA)-3’ respectively. PCR amplification
was performed using Platinum Taq (Life Technologies) in a home-made master mix
(1X Platinum Taq buffer, 2 mM MgCl2, 0.15% Triton-X, 1:2000 dilution of Rox dye,
1U Platinum Taq, 0.8 uM dNTP mix). Primer and probe concentration were 0.4 uM
and 0.25 uM respectively. The cycling protocol was: 2 minutes at 95°C followed by
40 cycles of a 30 seconds at 95°C denaturing step, a 30 seconds at 60°C annealing
step and a 30 seconds at 72°C extension step. Data was collected at every cycle
during the annealing step.
For experiments involving slowpoke exon C2 and dCrebA, the cDNA was
amplified by real-time PCR in an ABI Prism® 7700 Sequence Detection System
(Applied Biosystems) in the presence of SYBR Green I nucleic acid stain (Molecular
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Probes, Eugene, OR). The primers used to detect the slowpoke exon C2 were 5’-
gctatttataatagacgggccaagt -3’ and 5’- ggaaatccgaaagatacgaatgat -3’ while the primers
5’- ttcaactacctcagcacctatacga -3’ and 5’- tctcgatgtcggagcaaatg- 3’ were used to detect
the dCrebA message. PCR amplification was performed as for C1 but with 0.125 uM
SYBR Green I instead of the dual-labeled probe.
Each PCR was performed in triplicate and the yields thereof expressed as an
average. mRNA abundance was quantified using the standard curve method.
Significance was calculated using the Student’s t-Test. 
β-Galactosidase assay
Transcriptional activity of the transgenic slowpoke promoter after treatment
was determined by measuring beta-galactosidase specific activity. Protein extract was
prepared from P3 flies between 11 and 14 hours after solvent exposure and beta-
galactosidase activity determined (Ashburner, 1989). Total protein concentration was
determined using the Bradford-based Bio-Rad Protein Assay Kit following the
manufacturers instructions. Wild-type flies have a small level of endogenous beta-
galactosidase activity that was accounted for by subtraction. Significance was
calculated using the Student’s t-Test. 
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Chapter 3: Behavioral Responses to Serial Drug Exposure
Introduction 
In the last chapter it was proposed that the perturbation of excitability by
solvent sedation would induce homeostatic changes in channel gene expression. A
response of this kind should counter the effects of the solvent and if the response was
significantly large would reduce drug responsiveness. Although, the effects of
sedation with different solvents last no more than 30 minutes, transcriptional
responses are presumed to take up to several hours. It is thus predicted that a
homeostatic adaptation resulting from changes in gene expression will only become
apparent once the flies have recovered from exposure to the solvent. 
To test this hypothesis I tested whether a single exposure to benzyl alcohol
and the associated increase in the expression from the channel gene slowpoke would
result in the development of tolerance to a subsequent exposure to this drug. The term
“tolerance” is used to identify reduced drug responsiveness that results from prior
drug exposure (Chao and Nestler, 2004). Many different drug responses can be used
to demonstrate tolerance. Since the observed increase in slowpoke expression is
directly related to the sedative phase of solvent intoxication, it seems reasonable to
test a response that is associated to this phase. The length of time that the animals are
sedated is a direct response to the drug. Thus, a drug-induced reduction in the
duration of sedation fits the definition of tolerance. 
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Results
The benzyl alcohol tolerance assay
A common method that has been extensively used to measure sensitivity and
tolerance to volatile solvent in flies is the inebriometer. In this apparatus, originally
developed by Weber (1988), flies are placed in a cylinder fitted with a series of
baffles. When the cylinder is perfused with the vapors of an intoxicated drug, the flies
tumble through the baffles and are eluted at the bottom of the of the cylinder. A
measure of the mean time required for complete elution of the flies is indicative of the
sensitivity of the animals toward the drug. This assay have been successfully used in
the study of volatile general anesthetics (Weber, 1988; Krishnan and Nash, 1990;
Leibovitch et al., 1995) and ethanol (Moore et al., 1998). However, in this assay,
elution time is a result of the initial loss in ability of flies to maintain proper postural
control which is due to the drug-induced hyperactivity and not sedation. Since
slowpoke expression is directly dependent on sedation, this method is not appropriate
to test the effects of changes in slowpoke expression on sedation. 
Therefore, in this study I have used a variation of the "distribution test" that
has also been used to test sensitivity to volatile anesthetics (Guan et al., 2000). This
test takes advantage of the negative geotactic reflex, which causes flies to climb up
the walls of a container. When flies in a vial are exposed to a benzyl alcohol, they
become uncoordinated, lose their ability to climb, and fall to the bottom of the vial.
They eventually succumb to anesthesia and remain on the bottom of the vial.
Recovery from anesthesia can be recorded by monitoring the return of the negative
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geotactic behavior. 
In order to examine if flies develop tolerance to the effects of benzyl alcohol,
naïve flies can be treated with benzyl alcohol at two different moments. Tolerance is
said to have been induced if the animals recovered more rapidly from their second
benzyl alcohol sedation than from their first sedation (reduced drug responsiveness).
In order to allow for transcriptional changes to take effect, exposures to benzyl
alcohol are separated from each other by a 24 hour recovery period. 
As in every behavioral assay, variability is a major concern. In this assay, a
significant source of variability is the changes in humidity, temperature and air
pressure that affect the evaporation rates of benzyl alcohol and may result in a dose
change between exposures in different days. In order to properly detect changes in
recovery from sedation that are a result of tolerance, the doses used in the first and
second exposure must be equal. If the dose at the first exposure is larger than the dose
at a second exposure, there will be obvious difference in the recovery times from
sedation at each exposure that will result in false assessment of tolerance.
Unfortunately, day to day variations in atmospheric temperature and pressure, make it
impossible to ensure that benzyl alcohol is volatilized in the same way if the
exposures are done in different days. 
To solve this inconvenience, a population of naïve flies is divided in two
groups. On the first day, only one group is treated with benzyl alcohol and the other
group is left untreated. Twenty-four hours later, both groups are treated with benzyl
alcohol at the same time, thus the dose given to each group is essentially the same.
The only difference between groups is that for one group this is their first exposure
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while for the other this is their second exposure. Therefore, a difference in the
recovery time from anesthesia is a direct measure of the intrinsic sensitivity of each
group to the sedative effects of benzyl alcohol.
As second source of variability is of course the natural variations among
individuals or populations. To minimize this problem, all flies in each group are age-
matched female flies collected from a population reared in the same batch of food.
In order to accurately monitor the duration of sedation of each group, flies are
treated in transparent glass tubes. Snapshots are taken every 20 seconds during the
course of exposure and recovery with a digital camera under control of a computer.
Pictures are then used to analyze the position of flies in the glass tube. Recovery from
anesthesia is scored as the return of geotactic behavior. Flies on the walls of the tube
are scored as recovered. 
Figure 3.1 shows pictures of the same two groups of flies taken a different
time-points during the exposure and recovery periods . In each picture, the tube on the
left is the control group and received no treatment in a previous day, hence this is its
first exposure to benzyl alcohol. The group on the right was treated with benzyl
alcohol 24 hours prior to this exposure, therefore this is its second exposure. In this
pictures, one can observe that both groups knock-down simultaneously within the first
five minutes of exposure. However, when flies are transferred to recovery tubes with
no benzyl alcohol (at the tenth minute), the pre-treated group recovers at a faster pace
than the control group.
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1 min. 3 min. 5 min. 7 min.
1st 2nd
Figure 3.1: Benzyl alcohol tolerance assay. Sequential pictures of two vials
of flies taken at different times of exposure and recovery from 0.3 % benzyl
alcohol. The vial on the left of every picture, contains flies which have not
been treated before, this is their first exposure (1st). For the flies in the right
vial, this is their second exposure (2nd). The time point at which each picture
was taken is indicated under each picture as minutes after start of the
treatment. Time-points depicted over a black bar indicate the presence of the
solvent in the tubes while time-points depicted over a white bar indicate that
the solvent has been removed. Solvent was removed by transferring flies to
clean glass tubes at the end of the ninth minute (arrow).
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Benzyl alcohol-induced tolerance is dependent on slowpoke expression
It was noticed that a single benzyl alcohol exposure was sufficient to induce
tolerance to the drug. Tolerance was said to have been induced if the animals
recovered more rapidly from their second benzyl alcohol sedation than from their first
sedation (reduced drug responsiveness). Figure 3.2A shows that a population
previously treated with benzyl alcohol recovered approximately 5 minutes earlier than
naïve flies. The coincident increase in slowpoke mRNA levels with the induction of
tolerance prompted us to determine if the increase in slowpoke expression contributes
to tolerance. For this, the responses of the slo4 mutant were examined. The slo4
mutation is a chromosomal rearrangement that has a breakpoint in the slowpoke gene.
This mutation eliminates the production of channels from the gene (Becker et al.,
1995; Atkinson et al., 1991). Surprisingly, slo4 homozygotes are healthy and fecund
(Atkinson et al., 2000). The slo4 flies were subjected to the tolerance test described
above. Figure 3.2B shows that in the absence of slowpoke expression, prior benzyl
alcohol sedation does not induce drug tolerance. Instead, the previously treated slo4
flies appeared more sensitive and showed a slower recovery from anesthesia when
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Figure 3.2: Behavioral response to serial benzyl alcohol exposure.
Behavioral response to serial benzyl alcohol exposure. Knock down and
recovery curve of wild-type (A) and slo4 mutant flies (B) after one (thin line)
and two (thick line) exposures to 0.3% benzyl alcohol. Time between
exposures is 24 hours. Loss of climbing indicates sedation. Values are plotted
as a percentage of climbing flies against time at 20 second intervals. The
double asterisk indicates significant difference from control as determined by
the Log-Rank test (n = 3, p < 0.01). Error bars are SEM for each data point.
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Expression level of slowpoke is a predictor of drug sensitivity
To determine whether the level of slowpoke expression affects benzyl alcohol
responsiveness I manipulated slowpoke expression and measured drug
responsiveness. Expression was increased by using an inducible slowpoke transgene
or with drugs, and expression was reduced with environmental treatments. 
First, I tested the benzyl alcohol response of flies carrying a heat-inducible
slowpoke transgene. These animals are homozygous for the slo4 null allele and carry
the B52H transgene. B52H has an hsp70 promoter that drives expression of a
slowpoke cDNA (Atkinson et al., 1998) (Figures 3.3A and B). In this paradigm, heat
shock (37°C for 30 minutes) was used to induce the transgene and was substituted for
the first benzyl alcohol treatment. Twenty-four hours later the animals were sedated
with benzyl alcohol and their recovery time compared to age-matched B52H siblings
that were not heat shocked but that were otherwise treated identically. Heat shocked
flies were more resistant to benzyl alcohol and recovered faster than their non-heat
shocked siblings (Figure 3.3C). Real-time RT-PCR demonstrated that the heat pulse
induces expression from B52H (Figure 3.3B).
To determine if inducible resistance was merely a heat shock response that
was unassociated with the B52H transgene, I monitored, in parallel, the effect of heat
shock on wild type flies that do not carry the transgene. In wild type flies, heat shock









































































0 500 1000 1500 2000
No HS 
HS
Figure 3.3: Effects of slowpoke induction on recovery from benzyl alcohol
sedation. A) Map of the B52H transgenic construct (Atkinson et al., 1998) in
which the HSP70 promoter drives expression of a slowpoke cDNA. C2 and
C3 are two exons that are also shown in figure 1D. B) Relative slowpoke
expression levels in B52H transgenic flies, six hours after treatment with heat
shock (HS) or control (No HS). An asterisk indicates significant difference
from control (p < 0.01). C and D) Recovery curve of wild-type and the
HSP70-slowpoke transgenic flies (B52H) after exposure to 0.3% benzyl
alcohol. Effects of slowpoke induction on the recovery were determined by
treating the transgenic and wild type flies with a heat shock (thick line) 24
hours before the benzyl alcohol treatment or with no heat shock (thin line).
Loss of climbing indicates sedation. The double asterisk indicates significant
difference from control as determined by the Log-Rank test (p < 0.01). Error
bars are SEM for each data point.
49
A working hypothesis that accounts for these data is that sedation induces
slowpoke expression and increased slowpoke expression results in tolerance
(inducible-resistance). In concert with this hypothesis are the results of a dose-
response study using benzyl alcohol. Low doses that fail to sedate the animals
(0.15%) and do not cause an increase in slowpoke expression (Figure 2.1A) also fail
to induce drug tolerance (Figure 3.4A). On the other hand, higher doses that induce
sedation and slowpoke expression also cause tolerance. 
In a second test I determined the effects of chloroform-induced slowpoke
expression on the recovery rate from benzyl alcohol sedation. Chloroform which
sedates animals without causing them to pass through a hyperactive phase also
produces an increase in slowpoke expression (Figure 2.3). A single chloroform
sedation was sufficient to induce benzyl alcohol resistance. Figure 3.4B shows that a
population previously treated with chloroform recovered from benzyl alcohol
sedation more rapidly than naïve flies.
To determine the effect of decreasing slowpoke expression I relied on
environmental treatments that reduce slowpoke mRNA levels. Hyperkinetic behavior
induced with increased temperature (37°C) or by exposure to a non-sedating dose of
toluene was used to reduce slowpoke expression (Figure 2.3). The benzyl alcohol
sensitivity of the animals was measured twenty-four hours after exposure. Both the
heat pulse (Figure 3.3D) and toluene exposure (Figure 3.4C) not only reduce


























































Figure 3.4: Solvents that change slowpoke expression alter drug
responsiveness. A) Recovery of wild-type flies from 0.3% benzyl alcohol after
pre-treatment with 0.15%, 0.3% or 0.4% benzyl alcohol compared to non-pre-
treated control flies. B) Recovery of wild-type flies from 0.3 % benzyl alcohol
sedation after pre-treatment with chloroform compared to non-pre-treated
control flies. C) Recovery of wild-type flies from 0.3 % benzyl alcohol
sedation after pre-treatment with toluene compared to non-pre-treated control
flies. The asterisk indicates the recovery curves are significantly different from
control (* = p < 0.05; ** = p < 0.01). In panel B it indicates that the 0.3 and
0.4% pre-treatments are significantly different (** = p < 0.01) from control
(whereas the 0.15% pre-treatment is not). Error bars are standard error of the
mean calculated for each data point.
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Sedation with non-solvents has also been shown to cause an increase in
slowpoke expression. I wished to know if non-solvent-induced sedation could also
induce benzyl alcohol resistance. Carbon dioxide and cold sedation both induced
slowpoke expression in the absence of a hyperactive phase. But neither CO2 (Figure
3.5A) nor cold anesthesia (not shown) changed benzyl alcohol sensitivity. These
treatments induce less slowpoke expression than benzyl alcohol or chloroform (Figure
2.3B). They may not be sufficiently strong inducers of slowpoke expression to cause
benzyl alcohol resistance in normal animals. Therefore, I asked if any evidence of
CO2-induced benzyl alcohol resistance could be detected in flies sensitized to benzyl
alcohol anesthesia. Flies heat shocked to increase sensitivity were immediately
sedated with CO2. Interestingly, the CO2 treatment eliminated all evidence of heat-
induced sensitization (Figure 3.5B and 3.5C). This evidence suggests that CO2
sedation does increase benzyl alcohol resistance but that this effect can be detected






















































Figure 3.5: Non-solvent treatments that change slowpoke expression alter
drug responsiveness. A and B) Recovery of wild-type flies from 0.3 % benzyl
alcohol sedation after pre-treatment with CO2 (A) or heat followed by CO2 (B)
compared to non-pre-treated control flies. C) Recovery of wild-type flies from
benzyl alcohol after pre-treatment with heat and CO2 compared to flies pre-
treated with heat. The asterisks indicates the recovery curves are significantly
different from control (p < 0.01). Error bars are standard error of the mean
calculated for each data point.
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Neural-specific expression of slowpoke is necessary for drug tolerance
These studies have shown that up regulation of a neural-specific slowpoke
transcript is correlated with the appearance of benzyl alcohol tolerance and that a
slowpoke loss-of-function mutation prevents the acquisition of tolerance. However,
this loss-of-function mutation eliminated slowpoke expression in all tissues (neural,
muscular, epithelial). To demonstrate that tolerance was dependent only on neural-
expression of slowpoke the trans-heterozygotes mutant ash218/slo4 was used. The
ash218 allele is a chromosomal deletion that removes the two transcriptional
promoters that drive slowpoke neural expression. The promoter that drives expression
in muscle is still present (Atkinson et al., 2000). The ash218 allele is a recessive lethal
mutation because it also removes the ash2 (developmental) gene. Therefore, I used
ash218/slo4 trans-heterozygotes. Atkinson et al. (Atkinson et al., 2000) have shown
that this double mutant has specifically lost expression in the nervous system. These
flies were unable to acquire benzyl alcohol resistance (Figure 3.6A) whereas the slo4/
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Figure 3.6: Neural-specific expression of slowpoke is necessary for
induced drug resistance. A and B) Recovery curve of the ash218/slo4 trans-
heterozygous (A) and slo4/+ heterozygous flies (B) after one (thin line) and
two (thick line) exposures to 0.3% benzyl alcohol (24 hours between
exposures). Values are plotted as a percentage of climbing flies against time at
20 second intervals. An asterisk indicates significant difference from control




The term tolerance refers to reduced drug responsiveness that results from
prior drug exposure. Tolerance produced by a single brief exposure is termed “rapid
tolerance” (Scholz et al., 2000). Large-conductance calcium-activated potassium
(BK) channels, encoded by slowpoke, participate in regulating neuronal firing patterns
and neurotransmitter release. In flies, anesthetization with benzyl alcohol induces
both rapid tolerance and increased expression from the slowpoke Ca2+-activated K+
channel gene. Benzyl alcohol sedation does not evoke this response from the
slowpoke muscle-specific transcript following sedation. Results presented here
indicate that the sedation-induced increase in slowpoke expression contributes to
acquired benzyl alcohol tolerance. 
Scholz et al. (2000) have studied Drosophila rapid tolerance as induced by
ethanol sedation. They characterized tolerance by measuring the time or dose
necessary to sedate the animals. Sedation was defined as the point at which flies lost
postural control in an inebriometer or when the flies ceased movement. Using these
measures they showed that a single bout of ethanol sedation induces rapid tolerance.
They also demonstrated that a mutation interfering with octopamine biosynthesis
reduced the acquisition of rapid tolerance by 50%.
In this study I chose to use benzyl alcohol as a model solvent because it was
extremely easy to deliver and was extremely well tolerated by flies. With this
anesthetic, flies could be repetitively sedated without a loss of viability. For the
measurements of rapid tolerance I used a variation of the distribution test (Guan et al.,
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2000) in which a human observer records not the knock down time, but the period of
sedation. The specific hallmark of recovery that we scored was the resumption of wall
climbing. This means that the flies are not merely ‘conscious’ but that they are
sufficiently coordinated to implement a rather complex behavior.
I postulate that the benzyl alcohol-induced changes in slowpoke expression
reflect a homeostatic mechanism that resists untoward changes in net cellular
excitability. If hyperexcitability is induced, the proposed mechanism alters channel
expression to reduce this excitability, whereas if cellular excitability is suppressed,
channel gene expression changes to enhance excitability. This hypothesis does not
require that the activity of the slowpoke channel be directly affected by this solvent.
However, it has been shown that anesthetics and ethanol directly affect slowpoke
channel activity (Denson et al., 1996; Namba et al., 2000). In some cells, the solvents
inhibit channel activity while in others they potentiate the current.
Benzyl alcohol exposure results in an initial hyperkinetic phase followed by a
sedative phase. In the previous chapter, I have shown that the hyperkinetic phase
reduces slowpoke mRNA abundance and causes the drug sensitization. Conversely,
the sedative phase stimulates an increase in slowpoke expression and induces drug
tolerance. I propose that decreased slowpoke expression reduces the net excitability of
the nervous system while increased slowpoke expression enhances neural excitability.
Consistent with these interpretations are the observations that mutations that prevent
slowpoke expression interfere with the acquisition of tolerance while artificial
enhancement of slowpoke expression with a transgene causes a tolerant-like
phenotype. This observation indicates that the changes in slowpoke channel
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expression make a significant contribution to behavioral tolerance to benzyl alcohol
intoxication.
Upon a cursory consideration, these responses appear not to be homeostatic in
nature but to exacerbate the changed excitability of the nervous system. That is,
generically, one assumes that increased K+ channel activity would hyperpolarize the
cell and reduce excitability while reduced K+ channel activity would interfere with the
ability of the cell to terminate an electrical impulse and thereby enhance electrical
excitability. This role of slowpoke channels is well documented (Gribkoff et al., 2001;
Orio et al., 2002; Sun and Dale, 1998). However, there is substantial evidence that
slowpoke channel activity can also affect neural excitability in the opposite manner.
Warbington et al. (1996) have shown that loss of the slowpoke (BK) current in
flies leads to reduced motoneuron excitability and neurotransmitter release. It was
proposed that these changes occurred because the normal role of the slowpoke current
was to ensure rapid repolarization of the nerve terminal and, in the absence of the
slowpoke current, the increase in depolarization led to inactivation of voltage-gated
calcium channels. In a study in mammalian anterior pituitary cells it has been shown
that BK channel activation prolongs action potential duration, thus facilitating
extracellular Ca2+ entry (Van Goor et al., 2001). In this study, the authors show that
fast activation of BK channels by Ca2+ prevents the complete repolarization of the cell
by limiting the activation of voltage-gated potassium channels. This generates a
plateau potential which results in high-amplitude Ca2+ transients. Additionally, Lovell
and McCobb (2001) have shown that an increase in the open-probability of BK
channels enhances repetitive firing in chromaffin cells presumably by limiting
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activity-dependent inactivation of Ca2+ and Na+ channels. Finally, Pattillo et al.
(2001) have found that toxin blockade of BK channels in Xenopus nerve-muscle
synapses cultures significantly decreased transmitter release. They propose that this
decrease occurs because of the effect of the BK current on the driving force for Ca2+.
In all of these examples, an increase in the instantaneous excitability of the cell leads
to a reduction in long term or net excitability. Clearly, an increase in Ca2+-activated
K+ channel expression could elicit a positive rather than a negative effect upon
synaptic excitability and conversely, a reduction in slowpoke expression could reduce
neural excitability. 
Regardless of the mechanism, the data clearly suggests a role for the
modulation of slowpoke gene expression in the homeostatic regulation of excitability.
It is not suggested that slowpoke expression is responsible for all facets of tolerance.
This data indicates only that, in flies, slowpoke expression is required for the
acquisition of tolerance and that increased slowpoke expression can result in a degree
of benzyl alcohol resistance. It is likely that slowpoke is one component of an
orchestrated response of transcriptional changes and post-transcriptional
modifications that involves many genes. 
Recently, Davis et al. (2003) demonstrated that, in C. elegans, slowpoke loss-
of-function mutations cause ethanol resistance and that slowpoke over-expression
produces a phenotype that mimics ethanol intoxication. It is important to note that
slowpoke may play an opposing role in C. elegans with regard to its response to
drugs. I do not believe that the source of the difference is the choice of drugs. I
propose that, in Drosophila, the tolerance mounted to benzyl alcohol and to ethanol
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are related phenomenon because exposure to ethanol induces cross-tolerance to
benzyl alcohol (data not shown). The work in C. elegans focuses on resistance, per
se, and not on acquired tolerance. It seems unlikely that the origins of resistance and
acquired tolerance are sufficiently different to be influenced in opposing manners by
the same gene. A study by Leibovitch et al. (1995) has also suggested that there exists
a positive correlation between slowpoke expression and solvent anesthetic sensitivity.
This group demonstrated that a null mutation in slowpoke increased the sensitivity of
flies to halothane, chloroform and trichloroethylene. It is likely, therefore, that the
apparent differences in the role of slowpoke in the C. elegans and Drosophila drug
response has to do with the fundamentally distinct organization of the nervous system
of these animals. The most important consideration, is not the differences in how C.
elegans and Drosophila respond to changes in slowpoke expression, but in the fact
that studies in two very different organisms implicate slowpoke as having an




Drosophila stocks used in this study were Canton S (wild type), B52H, w1118,
slo4, +/slo4 and the ash218/slo4 trans-heterozygote. The genotype of the B52H
transgenic stock is w1118, B52H, slo4. In the B52H transgene, an inducible hsp70
promoter drives expression of a slowpoke cDNA whose splice pattern is found in the
nervous systems and muscles (Atkinson et al., 1998). The B52 transgene is
constitutively active but is substantially induced by a brief heat shock. Flies were
raised on standard cornmeal/molasses/agar medium at room temperature (25°C) in a
room with circadian control of illumination (12 light, 12 hours dark). Flies that
emerged from pupae were collected over a 2 day period, transferred to fresh food, and
studied three to five days later.
Benzyl alcohol tolerance assay
In the first exposure, flies were treated in triplicate with benzyl alcohol (0.3%)
or vehicle (100% acetone – evaporated to dryness) as described in Chapter 2. Twenty-
four hours later, treated and control flies were simultaneously exposed to benzyl
alcohol until all flies were sedated (approximately 10 minutes). At this point flies
were transferred to a solvent free glass vial for recovery. Snapshots were taken every
20 seconds during the course of exposure and recovery and stored as a stop-motion
movie. Recovery from anesthesia was scored as the return of geotactic behavior. Flies
on the walls of the tube were scored as recovered. Values for recovered flies were
then plotted as a percentage of the population in each tube (average of three tubes)
61
against time at 20-second intervals. The data and statistics shown in the figures are
derived from a protocol in which each assay is performed in triplicate. The entire
protocol has been repeated, in triplicate, a minimum of three times. Each repetition
yielded the same results.
For cross-tolerance or heat-shock experiments, a groups of flies were pre-
treated in triplicate with either chloroform, toluene, CO2, or heat-shock as described
in Chapter 2 and a control group was left untreated. Twenty-four hours later, treated
and control flies were simultaneously exposed to benzyl alcohol. Exposure and
recovery was monitored and recorded as explained above for benzyl alcohol
tolerance.
The Log Rank test for equality of survival was used to determine the
significant difference between recovery curves because survival analysis is best suited
for data in which one is measuring the time to a specific event (Hosmer et al., 2002).
In all of the tolerance assays we measure the time that it takes for each fly to recover
from sedation. The statistic evaluates if entire recovery curves are statistically
different (as opposed to individual data points comprised by the curve). However, in
behavioral assay we have also included error bars that represent the standard error of
the mean for each individual data point.
Quantitative real-time RT-PCR
Total RNA was extracted from 25 B52H flies 6 h after the start of the heat
shock or mock treatment by using a single-step RNA isolation tissue protocol as in
Chapter 2. mRNA expression from the B52H transgene was determined by
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quantifying abundance of the slowpoke exon C3 (found in the transgene) relative to a
Cyclophilin 1 (Cyp1) exon using the SYBR Green I nucleic acid stain real-time RT-
PCR assay as in Chapter 2. The primers used to detect exon C3 were 5' -
ttggccgacgatccaaca- 3' and 5' -accagtacttgcgcaccttga- 3'. Each PCR was performed in
triplicate, and the yields thereof were expressed as an average mRNA abundance was
quantified by using the standard curve method. Significance was calculated by using
Student’s t test.
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Chapter 4: Ion Channels, Memory, Sleep and Tolerance
Introduction 
Although the evidence presented so far implicates that in flies, slowpoke
expression is required for the acquisition of tolerance and that by itself increased
slowpoke expression can result in a degree of benzyl alcohol resistance, it is likely
that slowpoke is one component of an orchestrated response of transcriptional
changes and post-transcriptional modifications that involves many genes. In this
chapter, I have examined the role that other neurally expressed genes play in the
observed activity-dependent manifestations of tolerance to sedation by volatile
solvents in flies.
One obvious candidate group to test is composed of other voltage-gated ion
channel genes that, like slowpoke, are directly involved in shaping the electrical
properties of neurons. Changes in the expression of these channels can affect cell
resting potentials, action potential threshold and duration, repetitive firing,
neurotransmitter release and if co-regulated with slowpoke in response to volatile
solvents may also participate in the acquisition of tolerance to these drugs.  
In almost every case, voltage-gated ion channel genes found in Drosophila
have a mammalian homologs with striking similarities in sequence and function. Two
voltage-gated Na+ channels genes have been identified in Drosophila, para and DSC.
Both genes are widely expressed in the nervous system and have been shown to be
essential for action potential propagation. Several voltage-gated K+ channels from the
various mammalian subfamilies have also been found in Drosophila. Apart from
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slowpoke, which is the only BK-type channel encoded in Drosophila, there are at least
five Kv type channels involved in action potential repolarization; one KCNQ type,
associated with heritable human disorders; three EAG (one eag, one elk, and one erg),
mediating rapidly activating delayed rectifier K+ currents (IKr); three inward
rectifying Kir type channels, involved in both neuronal excitability and K+ transport;
and eleven TWIK K+ channels, which are modulated by a number of factors,
including pH, small signaling molecules, and membrane tension. Additionally, there
are at least four genes encoding voltage-gated Ca2+ channels, including homologs of
the mammalian T-type/α1G, L-type/α1D, and N-type/α1A genes (Littleton and
Ganetzky, 2000).
Although highly desirable, testing all of these genes represents a difficult task
to accomplish in a single study especially since mutants for all these genes are not
readily available. The ion channels tested here are: the well studied voltage-gated
sodium channel gene para (Stern et al., 1990), the L-type voltage-gated calcium
channel cacophony (cac) (Smith et al., 1996), and two voltage-gated potassium
channels: the A-type Kv channel Shaker (Sh) (Tempel et al., 1987) and the
Drosophila homolog of the human ERG seizure (sei) (Wang et al., 1997). Mutations
in these channels result serious alteration in neural excitability. Generally, mutations
that affect sodium or calcium channel function results in under-excitable cells,
whereas perturbations in potassium channel function results in hyperexcitability.
Another candidate group is that of genes involved in signaling pathways that
mediate activity-dependent changes in gene expression. One of the most studied and
best characterized neural signaling pathways that have been directly involved in
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activity-dependent behaviors, in both Drosophila and mammalian systems, is the
cAMP/Ca2+-CREB pathway. CREB (cAMP/Ca2+ Response Element Binding protein)
is a transcription factor activated by multiple protein kinases, including the cAMP-
dependent PKA, and several Ca2+-dependent protein kinases, such as the calcium/
calmodulin-dependent protein kinase type II (CaMKII) (Gonzalez et al., 1989;
Shaywitz and Greenberg, 1999). Gene regulation by CREB has been shown to
participate in learning and memory (Silva et al., 1998), in the cellular responses to
drugs of abuse (Nestler, 2004) and in the circadian regulation of behavioral activity
(Kako and Ishida, 1998).
Furthermore, in Drosophila the slowpoke and the dCrebA transcriptional
control regions contain CREB response elements, and both genes are simultaneously
up-regulated after benzyl alcohol sedation (Chapter 2). However, the signaling
pathways that couple changes in neural activity with the up-regulation of slowpoke
remain unknown. Studying the effects of manipulating genes involved in other CREB
mediated activity dependent behaviors on the phenomenon of tolerance may offer
clues into deciphering of the signaling pathways involved in this response.
Although multiple genes have been identified to be involved in learning and
memory and circadian rhythms, the dunce (dnc) and period (per) genes play central
roles in each of this pathways respectively and appear to be excellent tools to
investigate the involvement of CREB mediated signaling pathways in tolerance to
sedation. On one hand, dunce encodes a cAMP-specific phosphodiesterase that when
mutated, it has been shown to interfere with learning in several of the conditioning
tests involving odors and electric shocks or sugars (Dudai et al., 1976; Aceves-Pina et
66
al., 1983; Tempel et al., 1983). On the other hand, period encodes a PAS domain
protein that is essential for biological clock functions and determines the period
length of circadian and ultradian behavioral rhythms of activity(Reddy et al., 1984).
Mutations in per cause flies to have aberrant circadian rhythms including eclosion and
locomotor activity (Konopka and Benzer, 1971). 
Although these two genes do not have a direct involvement in the electrical
properties of cells, they are part of signal transduction pathways that modulate gene
products and the expression of genes involved in synaptic plasticity. I have used




To examine the implications that other genes have in tolerance, I have
followed a similar methodology to the one used in the previous chapters for slowpoke.
First, the expression patterns of the various ion channel genes mentioned above was
tested by quantification of their transcript abundance in response to benzyl alcohol-
induced sedation or toluene-induced hyperactivity. Secondly, I tested mutants in three
of these ion channel genes and in the two signal transduction genes to determine if
expression of their gene products is necessary for tolerance to benzyl alcohol or if any
change in excitability caused by these mutations alters in any way the phenomenon of
tolerance. Expression patterns of period and dunce were not examined since these are
expected to mediate gene transcription events rather than be regulated themselves.
Expression of other ion channels is not affected by solvent-induce changes in 
neural activity
The mRNA levels for para, Shaker, seizure and cacophony was measured in
flies six hours after treatment with benzyl alcohol and toluene using real-time RT-
PCR. Surprisingly, these treatment did not cause significant changes in the abundance
of the Shaker or seizure voltage-gated K+ channel mRNAs, the para voltage-gated































































































































Figure 4.1: Expression patterns of other channels is not affected by solvent
exposure. The mRNA abundance of various ion channels was measured
relative to Cyclophilin 1 by real-time RT-PCR from wild type flies that were
treated with either 0.4% benzyl alcohol (BA), toluene or were left untreated
(Control). The abscissa shows normalized mRNA levels from the each gene
relative to control animals that were not exposed to solvents but were
otherwise treated identically. Error bars show standard error of the mean.
69
Mutations in para, Shaker and seizure do not block tolerance to benzyl alcohol
To further explore the role of these ion channels genes in tolerance, mutants in
this channels were tested in the benzyl alcohol tolerance assay. The mutants alleles
tested were para63, ShKS133 and sei1. Mutants in cacophony were not tested since
mutants for this ion channels are either lethal or conditional temperature sensitive
hypomorphs (partial loss of function).
The para63 mutation in the voltage-gated Na+ channel is also a temperature
sensitive allele which becomes paralyzed at elevated temperatures. However, even at
room temperature this mutant exhibits significant neurophysiological defects (Huang
and Stern, 2002). The para gene is located on the X chromosome. In the tolerance
test, only male flies containing a single mutated copy of the gene were used. After a
single benzyl alcohol exposure, this mutant showed normal tolerance to benzyl
alcohol at their second exposure (Figure 4.2A). Additionally, careful observation of
the behavior elicited during the exposure to benzyl alcohol revealed that this mutant
did not get as hyperactive as wild-type flies at the initial phase of the intoxication
with benzyl alcohol and became sedated rapidly.
Similarly, the ShKS133 and sei1 null missense mutations in two different
potassium channels in flies (Lichtinghagen et al., 1990; Wang et al., 1997) were not
able to block tolerance to benzyl alcohol. Interestingly, contrary to the para mutant,
both of these mutants became extremely hyperactive as soon as they were exposed to
the drug. In addition, it was observed that in the second exposure Shaker mutants































































































































Figure 4.2: Mutants in other ion channel genes show tolerance to benzyl
alcohol. Recovery curve of the para63 (A), the ShKS133 (B) and sei1 mutants (C)
after one (thin line) and two (thick line) exposures to 0.3% benzyl alcohol (24
hours between exposures). Values are plotted as a percentage of climbing flies
against time at 30 second intervals. An asterisk indicates significant difference
from control (n=4, p< 0.05). Error bars are standard error of the mean
calculated for each data point.
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A mutation in period blocks tolerance to benzyl alcohol
Previously, I have shown that the acquisition of tolerance to solvent
anesthetics is dependent on changes in the expression of the slowpoke ion channel
gene. This changes appears to be in direct response to changes in the excitability of
the nervous system cause by solvent intoxication. Mechanistically, it is thought that
activity-dependent regulation of gene expression is carried-out by signal transduction
pathways that sense changes in cellular activity and signal to transcription factors that
in turn activate or inhibit gene expression. Here, I used mutations in two different
genes to independently block two signal transduction pathways that have been shown
to be involved in controlling activity-dependent changes in gene expression. 
The first mutant tested was dnc1. This mutant eliminates one form of cAMP
phosphodiesterase activity (Kauvar, 1982) resulting in increased levels of cAMP
(Davis and Kauvar, 1984) and of phosphorylation of the regulatory subunit of a
cAMP-dependent kinase (Muller and Spatz, 1989). However, when subjected to the
benzyl alcohol tolerance test described previously showed normal acquisition of
tolerance (Figure 4.3A) suggesting that changes in cAMP levels do not interfere with
tolerance in flies.
The second mutant tested was per01. This mutant eliminates a PAS domain
protein that is essential for biological clock functions. The per01 flies were subjected
to the tolerance test. Figure 4.3B shows that in this mutant, prior benzyl alcohol































































































































Figure 4.3: Benzyl alcohol tolerance in signal transduction mutants.
Recovery curve of the dnc1 (A) and the per01 (B) mutant after one (thin line)
and two (thick line) exposures to 0.3% benzyl alcohol (24 hours between
exposures). Values are plotted as a percentage of climbing flies against time at
30 second intervals. An asterisk indicates significant difference from control




In neurons, electrical activity is established by the combination of different
ion channels expressed in these cells. In Drosophila (as in mammals) the repertoire of
voltage-gated ion channel genes that a specific cell can express is very large and
diverse (Littleton and Ganetzky, 2000). The heterogeneous physiological properties
of the different channels gene products allows for appropriate molding of the action
potential waveforms characteristic of different neural types but more importantly,
provides great flexibility in orchestrating modulation of neural activity in response to
sudden changes in excitability (Levitan and Takimoto, 1998). 
Surprisingly, of all voltage-gated ion channels tested so far, only the Ca+
activated voltage-gated K+ channel encoded by the slowpoke gene shows changes in
expression in response to sedation and hyperactivity induced by volatile solvents.
Neither the Shaker, seizure, para or cacophony voltage-gated ion channel mRNAs
show a significant changes in expression following intoxication by benzyl alcohol or
toluene. This suggests that the changes in slowpoke are not part of a generalized
response that affect transcription from all channel genes. Furthermore, whereas a
mutation in slowpoke was sufficient to block tolerance, mutations in the other genes
tested did not interfere with the ability of flies to acquire tolerance, suggesting a
unique role for slowpoke in this phenomenon.  
It is worth noting however, that the changes in excitability produced in these
mutants, may instead affect the sensitivity to the first exposure to benzyl alcohol. It
was observed that in the hyperexcitable seizure and Shaker K+ channel mutants, the
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hyperactive phase of intoxication was clearly enhanced when compared to wild-type
animals whereas the decreased excitability caused by the Na+ channel mutation para,
decreased the excitable phase of intoxication. Unfortunately, the methodology used in
the tolerance assays fails to report this effects and thus can not be measured in a
quantifiable way. These observations were made from visual assessment of behavior
and may be unreliable. Perhaps, a more sensitive assay that is able to detect net
locomotor activity in flies, and not just their climbing abilities, might give better
insight into these effects. This methods are currently been developed in the lab.
Although it is clear that mutations in several of these genes affect the level of
sensitivity to specific pharmacological effects of solvent intoxication, changes in their
expression patterns are not required for developing tolerance. This data argues that
the principle behind tolerance does not necessarily revolve around set levels of
sensitivity or resistance towards a specific drug. Rather, tolerance implicates the
capacity to produce significant changes in sensitivity in an experience dependent
manner. Interestingly, the ion conductance for slowpoke channels are up to 10 times
larger than all of the channels tested (Wicher et al., 2001). A change in slowpoke
alone would thus have a greater impact on the excitability of a neuron, making it a
reasonable choice for generating large changes in cellular excitability at a lower
transcriptional cost. 
However, such transcriptional specificity requires precise control of the
coupling between changes in activity and changes in gene expression. Furthermore, it
is essential that the homeostatic regulations of neural activity do not interfere with the
activity of non-homeostatic, Hebbian, activity dependent modifications of neural
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circuitry, but instead set the appropriate physiological limits for such changes to
occur without resulting in destabilization of neural function (Turrigiano and Nelson,
2000). One hypothesis is that at the transcriptional level, the separation between
Hebbian plasticity and homeostatic adaptations might involve independent control of
activity-dependent regulation of gene expression through different transcription
factors, different signaling pathways or even a spatial separation between the two
processes. 
The transcription factor CREB has drawn especial attention in the activity-
dependent regulation of gene expression since its activation involves many signaling
pathways linked to several second messenger systems directly related to changes in
membrane depolarization such as changes in intracellular cAMP and/or calcium.
In the cAMP second messenger cascade, accumulation of cAMP in response
to activation G-protein-coupled receptors induces activation of CREB by
phosphorylation through the cAMP-dependent protein kinase (PKA) (Mayr and
Montminy, 2001). Once activated, CREB mediates cellular gene expression by
binding as a dimer to a conserved cAMP-responsive element (CRE), TGACGTCA,
found in the transcriptional control regions of several CREB target genes.
Phosphorylation of CREB also promotes recruitment of the transcriptional co-
activator CBP (CREB binding protein) (Mayr and Montminy, 2001).
Gene regulation by the cAMP/CREB signaling pathway has been strongly
implicated in Hebbian synaptic plasticity that is associated with long-term memory
(Silva et al., 1998; Yin and Tully, 1996; Bourtchuladze et al., 1994; Bartsch et al.,
1998). In Drosophila a mutation in dunce, a cAMP phosphodiesterase, results in
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increased levels of cAMP and of phosphorylation of the regulatory subunit of PKA
(Davis and Kauvar, 1984; Muller and Spatz, 1989) and has been shown to interfere
with learning and the associated formation of memory (Dudai et al., 1976; Aceves-
Pina et al., 1983; Tempel et al., 1983). However, as shown in this study, this mutation
does not completely block the acquisition of tolerance to benzyl alcohol, suggesting
that tolerance is not dependent on the cAMP cascade.
Intriguingly, the slowpoke transcriptional control region contains at least two
CRE sequences and shows a coincident up-regulation, after benzyl alcohol sedation,
with another CRE regulated gene, dCrebA. This gene encodes one member of the
CREB family of genes in Drosophila, dCREB-A, and is thought to auto-regulate it
self (Rose et al., 1997). Although this evidence points towards a CREB mediated
regulation of slowpoke after sedation, it seems clear that the activation of this
pathway is through a cAMP-independent signal. 
Many studies have shown in fact, that CREB can also be activated by cAMP-
independent calcium signals. For instance, Pokorska and colleagues (2003) have
shown that synaptic activity induces signaling to CREB without increasing global
levels of cAMP in hippocampal neurons. In another study, Greenberg and colleagues
(1992) showed that in cultured cells, CREB functions as a Ca2+ regulated
transcription factor and suggested a model whereby activation of voltage sensitive
Ca2+ channels stimulates activation of a calcium/calmodulin-dependent (CaM) kinase
leading to CREB phosphorylation transcriptional activation. 
Interestingly, the CREB family member encoded by the Drosophila dCrebA
contains three CaM Kinase II phosphorylation sites but no PKA phosphorylation sites
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(Smolik et al., 1992). This evidence may suggest that the changes in calcium entry
associated with sedation by volatile solvents and anesthetics result in the up-
regulation of the slowpoke gene presumably from the activation of dCREB-A by a
CaM kinase signaling pathway. 
A different Drosophila cAMP/PKA-activated CREB family member is
dCREB-B and is encoded by the dCrebB-17A gene. Interestingly, expression from the
dCrebB-17A gene also generates an alternative spliced product that is a highly
conserved homolog of the mammalian cAMP-dependent transcription repressor
CREM (cAMP response element modulator) which acts as a specific antagonist of
cAMP-inducible transcription (Yin et al., 1995). The dCrebB-17A gene may thus be
responsible for alternative regulation of CRE mediated genes in a cAMP-dependent
manner including those involve in learning and memory (Yin et al., 1994) and
perhaps even in the down-regulation of slowpoke induced by hyperactivity events
(toluene exposure) that lead to sensitization rather than tolerance to sedation.
A more complex scenario is unraveled when one takes a look at the circadian
regulation of rest and activity cycles involved in sleep patterns. Rhythmic cycles
between arousal and sleep indicate an endogenous component responsible for the
regulation of arousal states. Interestingly, when sleeping, animals display very similar
behavioral phenotypes to those observed during anesthesia: unconscious states
characterized by the lack arousal by auditory, olfactory, somatic and visual stimuli
and even electroencephalographic activities that are strikingly similar to those during
certain sleep states (Contreras and Steriade, 1996). Studies of sleep regulation can
thus offer helpful insights into the mechanisms that result in sedation with drugs. Two
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independent studies have shown that sleep in flies share many critical features with
mammalian sleep, including prolonged immobility, decreased sensory responsiveness
and a even a homeostatic rebound period after rest deprivation (Hendricks et al.,
2000; Shaw et al., 2000). 
Rhythmic rest and activity cycles in flies are under control of a cell-
autonomous molecular clock produced by the transcriptional negative feedback loop
of key intracellular proteins. Of these proteins, the two best characterized are encoded
by the period (per) and timeless (tim) genes (Konopka and Benzer, 1971; Myers et
al., 1995). These molecular oscillations are thought to generate changes in locomotor
activity and other physiological processes through the rhythmic control of the
expression of numerous key output genes (Ceriani et al., 2002; Claridge-Chang et al.,
2001). 
Expression of slowpoke has been shown to cycle in a circadian manner.
Furthermore, the slo4 null mutation (the same one used to block tolerance to benzyl
alcohol) results in behavioral arrhythmicity, which implicates slowpoke as a central
regulator of circadian locomotor activity (Ceriani et al., 2002). Interestingly, as
shown here, disruption of the circadian clock by a mutation in the per gene, also
blocks the slowpoke dependent tolerance to benzyl alcohol. This result suggest that
the mechanisms mediating circadian regulation of activity may also be involved in the
generation of homeostatic responses to changes in activity by many drugs. However,
the mechanisms by which clock genes mediate the circadian regulation of slowpoke,
or the slowpoke dependent homeostatic responses remains unclear. 
One interesting possibility involves CREB. Experiments conducted in
79
Drosophila by Belvin and colleagues (1999), using an in vivo assay that monitors the
expression of a luciferase reporter transgene fused to a CRE sequence, have shown
that CREB responsive gene expression (of the reporter) has a circadian pattern.
However, whether the cycling of the reporter is mediated by dCREB-A or dCREB/
CREM-B or if it is cAMP- or Ca2+-dependent remains unclear. Belvin et al. (1999)
showed that the circadian patterns of the CRE-luciferase reporter gene expression
were affected by mutations in dCrebB and in genes involved in the cAMP pathway,
but were not completely abolished. This suggest that circadian activation of CRE-
mediated expression might involve more than one signal. Interestingly, other studies
have shown that in mammals, activity-dependent cytoplasmic calcium levels and
NMDA-evoked calcium currents in the suprachiasmatic nucleus oscillate in a
circadian manner (Colwell, 2000; Colwell, 2001). This data suggest that circadian
modulation of behavioral activity may be mediated through CREB by both calcium
and cAMP signals.
In order to effectively mediate cycling of high and low levels of expression
from clock output genes within one circadian period, it seem fairly reasonable to
expect that a CRE-mediated circadian expression involves both activation and
repression of transcription that alternate through the day. If so, then this can be
achieved by the activation of transcription through Ca2+-dependent dCREB-A
activation and repression through cAMP-dependent dCREB-B activation. 
Additional speculations about the mechanisms by which clock genes mediate
changes in arousal states through the circadian regulation of slowpoke, or slowpoke
dependent homeostatic responses can be made from experiments performed on the
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sleep rebound phenomenon.
In two independent studies (Hendricks et al., 2000; Shaw et al., 2000) it was
shown that as in mammals, flies exhibit a homeostatic rebound period after rest
deprivation. In these studies scientist have shown that a fly's resting period after
stimuli driven rest deprivation is significantly increased but the timing of the rest–
activity cycle was not altered. Suggesting a homeostatic mechanism that mimics that
of cross-sensitization to sedation after exposure to hyperactivity inducing solvents
(i.e. toluene, Figure 3.4C). In this analogy, the sleep depriving stimulus (mechanical)
resembles the hyperactive state induced by toluene pre-exposure while the rebound
prolongation of sleep resembles the increased duration of sedation by benzyl alcohol.
Interestingly, Hendricks and colleagues (2000) also showed that the
homeostatic sleep rebound response was blocked in tim mutant flies but remained
normal in per mutant flies. Furthermore, a transgene carrying tim under control of the
tim promoter, rescued the rest rebound in the tim mutant. These results led the authors
to conclude that even thought together per and tim are essential for circadian function,
the role of the two genes in rest homeostasis might be different and independent from
the circadian clock (as per mutants are arrhythmic, and still show significant rest
rebound). Clearly, tim has a function in rest homeostasis that goes beyond its central
clock function. In contrast, I have shown that a mutation in per blocks tolerance to
sedation by benzyl alcohol, suggesting a role for per that goes beyond its central
clock function. 
Although there are many interpretations to this result, one interesting
hypothesis is that the homeostatic mechanisms that mediate the responses to
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hyperactivity (sleep deprivation) and to underactivity (sedation by anesthetics) are
mediated by two different clock genes. Perhaps, tim alone somehow mediates
repression of CRE-responsive genes (i.e. slowpoke) through cAMP-dependent
activation of the repressor form of dCREB-B (CREM) leading to decreased of arousal
states (prolonged sleep). While per alone somehow mediates the activation of CRE-
responsive genes (i.e. slowpoke) through Ca2+-dependent activation of dCREB-A
resulting in higher arousal states (tolerance to sedation).
Unfortunately, whether the clock genes independently modulate slowpoke
expression in opposite ways is not know. Neither it is known if different second
messenger signals mediate opposing CREB effects in slowpoke. But the experiments
discussed here clearly involve a very complex mechanism by which the two clock
components acting as a molecular complex mediate the natural variations in
behavioral activity, and when acting independently mediate homeostatic responses to





All flies used in the experiments discussed in this chapter were raised on
standard cornmeal/molasses/agar medium. Flies were kept in a room with constant
temperature (22 oC) and 12:12 hrs light:dark cycles. Flies that emerged from pupae
were collected over a 2-day period, transferred to fresh food, and studied between
three to five days later. In this way, all flies are roughly between five to seven days
old. Genotype of mutant stocks were ShKS133, seits1, dnc1, per01 and para63/x^x. 
Benzyl alcohol tolerance assay
Benzyl alcohol tolerance was determined as described earlier (Chapter 3,
Methods) with a few modifications. In the first exposure, flies were treated in
replicates of four with benzyl alcohol (0.3%) or vehicle (100% acetone – evaporated
to dryness) as described in Chapter 2. Twenty-four hours later, treated and control
flies were simultaneously exposed to benzyl alcohol until all flies were sedated
(approximately 10 minutes). At this point flies were transferred to a solvent free glass
vial for recovery. Snapshots were taken every 30 seconds during the course of
exposure and recovery and stored as a stop-motion movie. Recovery from anesthesia
was scored as the return of geotactic behavior. Flies on the walls of the tube were
scored as recovered. Values for recovered flies were then plotted as a percentage of
the population in each tube (average of four tubes) against time at 30-second
intervals. The data and statistics shown in the figures are derived from a protocol in
which each assay is performed four times. The Log Rank test for equality of survival
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was used to determine the significant difference between recovery curves because
survival analysis is best suited for data in which one is measuring the time to a
specific event (Hosmer et al., 2002). However, in behavioral assay we have also
included error bars that represent the standard error of the mean for each individual
data point.
Quantitative real-time RT-PCR
Total RNA was extracted from 25 wild type flies 6 h after the start of the
treatment by using a single-step RNA isolation tissue protocol as in Chapter 2. The
mRNA expression from the para, seizure, cacophony and Shaker genes was
determined by quantifying abundance relative to Cyclophilin 1 (Cyp1) using the
SYBR Green I nucleic acid stain real-time RT-PCR assay as in Chapter 2. The
primers used were: 
–  para: 5' -ggtgctgcgagcgcttaa- 3'  and 5' -ggataatcacatcgcgcagat- 3'. 
–  seizure: 5' -tggtgatgtacacggccatt- 3'  and 5' -atgacaattggatcggagttgat- 3'.
–  Shaker: 5' -gcggattaaggtttgagacacaa- 3'  and 5' -gtaccgtaatctccgagctggat- 3'.
–  Cacophony: 5' -tagtgaaggagggcgaatcaga- 3'  and 5' -gcttgtggtgttattgcatacgaa- 3'.
–  Cyclophilin 1: 5' -accaaccacaacggcactg- 3’ and 5’ -tgcttcagctcgaagttctcatc- 3’.
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Chapter 5: Electrophysiological Effects of slowpoke Modulation
Introduction
The studies presented in the previous chapters have demonstrated that an
increase in the expression of the gene slowpoke is both sufficient and necessary for
the development of tolerance to sedation from anesthetics. As discussed previously,
this evidence suggests that the molecular response and the long-term behavioral
consequences of sedation manifested in the form of rapid drug tolerance are cause
and effect of a homeostatic mechanism that modulates neuronal excitability (Ghezzi
et al., 2004). One hypothesis is that the increased BK channel expression from the
slowpoke gene enhances net neural excitability and thereby helps the nervous system
to resist sedation.
Although it is generally expected that increased K+ channel activity would
cause hyperpolarization of the cell and reduce neural excitability (Sun and Dale,
1998; Orio et al., 2002; Gribkoff et al., 2001) there is also substantial evidence that
increased slowpoke channel activity can induce an opposite effect on neural
excitability of certain circuits. It has been proposed that a fast re-polarization of
membrane potentials by the slowpoke channel will prevent the prolonged inactivation
of voltage-gated calcium channels that mediate calcium dependent transmitter release,
thus reducing the refractory period of the channel and allowing an increase in
repetitive firing (Warbington et al., 1996; Lovell and McCobb, 2001; Pattillo et al.,
2001). 
However, the long term effects of the up-regulation of the slowpoke gene on
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the excitability of a neural circuit in Drosophila remain unknown. It is also unclear
whether the effects will be in any way similar to the ones elicited by sedation so as to
explain the role of slowpoke in tolerance to drugs. In this chapter, I explore the long-
term effects of sedation and the up-regulation of slowpoke on the excitability of the
giant fiber pathway, a very well characterized neural pathway involved in the visual
escape response in Drosophila and that is well suited to answer this particular
question.
The visual escape response is the fly's instinctive reflex to escape after sudden
changes in light intensity. The escape response can be elicited experimentally by
electrical stimulation across the fly's brain. This stimulus is thought to activate a pair
of interneurons called the giant fibers that descend from the brain into the thoracic
central nervous system and subsequently activate several muscles involved in
jumping and flying and mediate the escape response. The response can be accurately
monitored by recording from these muscles (Wyman et al., 1984).
Previous studies have shown that during sedation by anesthetics, electrical
induction of this pathway is significantly inhibited in a dose dependent manner (Lin
and Nash, 1996). Therefore, this preparation offers an invaluable tool to directly
study the long term physiological effects of sedation-induced slowpoke expression
over a simple but relevant neuronal circuit.
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Results
The giant fiber pathway in Drosophila
In the giant fiber pathway, the giant fiber conducts action potentials from the
brain, through the cervical connective that links the head to the thorax. In the thorax,
the giant fiber synapses with an inter-neuron (electrical synapse) which connects to a
motor neuron that terminates on the dorsal longitudinal (DLM) flight muscles
(Wyman et al., 1984). Electrical stimulation of the giant fiber circuit by electrodes
placed on the eye elicit, after a short delay, evoked potentials in the DLM that can be
recorded by an electrode placed dorsally in the thorax (Figure 5.1A). As the intensity
of the stimulation increases, the latency (delay) of the response undergoes distinct
shifts in duration. At relatively low stimulating voltages (10-16 volts) the response in
the muscle appears with a latency of approximately 4 ms. This response is usually
called the long latency (LL) response (Elkins and Ganetzky, 1990; Engel and Wu,
1996; Lin and Nash, 1996). At higher voltages (18+ volts) the latency drops to a
surprisingly constant 1.4 ms, and is referred as the short latency (SL) response. In
some cases an intermediate latency response (IL) of approximately 2 ms can also be
detected (Figure 5.1B).
It has being suggested (Levin and Tracey, 1973; Tanouye and Wyman, 1980),
that with small voltages, stimulation of the brain will trigger the activation of afferent
neurons located pre-synaptically to the giant fiber. Thus, the long latency response
will result from the subsequent activation of the giant fiber. On the other hand, higher
voltages that propagate across a larger area of the brain, will directly activate the



















































Figure 5.1: The giant fiber pathway. A) In the giant fiber pathway, the
giant fiber, which receives inputs from visual or other neural afferent
pathways (aff.) is electrically connected to the peripheral synapsing
interneuron (PSI) which activates the DLM motoneurons (DLMmn). The
DLMmn synapses upon the dorso-longitundinal flight muscle (DLM).
Stimulating potentials, passed through electrodes on the eyes, activate neural
afferent pathways (aff.) that trigger a response that can be recorded by an
electrode in the DLM. B) Different stimulating voltages will trigger the
activation of the pathway at different points, resulting in responses with
different latencies that can be divided in three main categories: long,
intermediate and short. Traces show typical long, intermediate and short
latency responses evoked by brain stimulation. C) Response latencies from a
single fly plotted as a function of increasing stimulating voltage. Increasing
the stimulus voltage decreases the latency of the evoke response. The three
different groups can be clearly distinguished. The larger potentials are thought
to directly trigger activation of the giant fiber and have a very constant short
latency of approximately 1.4 ms.
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The following frequency of the giant fiber pathway
In order to accurately measure the excitability of a neural circuit involved in
the giant fiber pathway I have chosen to measure the ability of the system to follow
high frequency stimulation. This type of stimulation offers a reliable way to measure
the refractory period of the circuit (Lin and Nash, 1996; Engel and Wu, 1992). For
this, trains of stimuli at ever increasing frequency were delivered to determine the
following frequency of the response from the giant fiber pathway. 
Although the following frequencies of both the short and long latency
responses can be tested in this way, the long latency response is significantly more
sensitive to high frequency stimulation than the short latency response as well as
more variable. In fact, as shown in Figure 5.1C, individual long latency responses
actually include a wide range of different latencies that change slightly with small
changes in the stimulating voltages. This may be an indicative of a complex set of
unknown afferent pathways that trigger the activation of the giant fiber and that will
be activated differently by small changes in electrode placement and thus resulting in
recordings with high variability between flies. On the contrary, the short-latency
response is extremely constant and is stable in response to high frequency stimuli
(Tanouye and Wyman, 1980) offering a more precise way to detect small changes in
excitability like the one expected to happen after slowpoke induction. The short
latency response was thus chosen for determining the following frequency in all
subsequent experiments.
Three trains of ten stimuli were delivered and the number of failures counted.
A failure is the absence of an action potential in the muscle in response to an evoked
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stimulation. The frequency of the stimulus trains was gradually increased and as the
refractory period was exceeded the neurons failed to fire. The animals were allowed
to rest between each stimulus train. In this manner, we identified a stimulation
frequency that was too high for the pathway to follow. Then the last successful
frequency was re-tested to confirm that the giant fiber pathway was not exhausted.
The following frequency with 50% response (FF50) was also determined by linear
interpolation (Engel and Wu, 1992). Since the FF50 was calculated from the linear
phase of the frequency response curve for each fly, it is an independent measure of
the response rates compared to that calculated from the frequency response curves. 
It was reasoned that a decrease in the refractory period would lead to a
increase in the following frequency of the neural circuit. If increased slowpoke
expression enhanced neural excitability by reducing the refractory period, then we
should observe a higher following frequency in animals in which expression of the
slowpoke gene was induced.
In order for this method to produce an accurate report of the following
frequency of the neurons in the giant fiber pathway, the following frequency of the
flight muscle must substantially exceed that of neurons. In figure 5.2, I compared the
following frequency of the giant fiber pathway and flight muscle directly stimulated
with an extracellular electrode. As expected, low frequency stimulation of the short-
latency pathway elicits responses in the muscle for each of the 30 stimuli. However at
stimulation frequencies higher than 80 Hz, the circuit becomes refractory and no
response is detected from the DLM muscle. This muscle however, when stimulated
directly at the thoracic ganglion, will fire successfully even after stimulating
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frequencies higher than 240 Hz suggesting that the failures seen after the giant fiber






































Figure 5.2: Frequency characteristics of the S-L and direct muscle
stimulation. The following frequency of the short-latency response of the
giant fiber pathway was determined. Three trains of ten stimuli were delivered
through the eyes at different frequencies and actions potentials recorded at the
end of the giant fiber pathway in the DLM (SL, open boxes). Responses (out
of 30 possible) at each frequency were counted and plotted against frequency.
Closed circles are DLM action potentials produced by direct-muscle
stimulation via electrodes in the thoracic ganglion. Note that the capacity of
the DLM to follow high frequency stimulations far exceeds that of the giant
fiber pathway. Error bars are SEM, n=5.
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Sedation enhances excitability of the giant fiber pathway
To test if sedation causes long term effects on the excitability of the giant fiber
pathway, the following frequency of the short latency response of flies that have
being previously sedated with benzyl alcohol was determined.
A single benzyl alcohol sedation, twenty-four hours prior, substantially
increases slowpoke expression (chapter 2). Figure 5.3 shows that it also increases the
following frequency of the giant fiber pathway. A significant rightward shift in the
frequency response curve is observed (Figure 5.3A) with an average increase in the
FF50 of 32 hertz (27%) over the non treated control (Figure 5.3B). To test whether
the loss of slowpoke expression, which prevents the acquisition of sedation-induced
tolerance, also blocks this electrophysiological phenotype, the effects of sedation in
the following frequency of a slowpoke mutant was tested. However, elimination of
slowpoke expression in muscles would cause a broadening in the evoked potentials
recorded from the DLM (Brenner et al., 2000) and interfere with this assay.
Previously, It has been shown that the ash218/slo4 heteroallelic combination can be
used to eliminate slowpoke expression from neurons but not from muscles. The ash218
mutation is a small, recessive lethal deletion which removes the neighboring gene and
also the transcriptional promoters that drive slowpoke in neurons. Fortunately, the
muscle promoter is intact and functional. The intrinsic electrophysiological properties
of flight muscle in ash218/slo4 transheterozygotes appears normal (Atkinson et al.,
2000). Figure 5.3C and 5.3D show that prior sedation fails to produce an increase in
following frequency in the ash218/slo4 animals, indicating that genetic ablation of




































































































Figure 5.3: Sedation enhances the following frequency of the neural visual
escape pathway and is dependent on a functional slowpoke gene. Sets of three
trains of ten stimuli where delivered at different test frequencies through large
voltage stimulation on the eyes (SL) to animals that were sedated with benzyl
alcohol for 30 minutes 24 hours earlier (open boxes) or age-matched controls
that were not sedated (closed circles). The number of responses (out of a total
of 30 possible) at each frequency were counted and plotted against frequency
(A and C). Additionally, the following frequency with 50% response (FF50)
for each animal was calculated by interpolation (B and D). A-B) Previously
sedated wild type CS flies which have a functional slowpoke gene show a
significant rightward shift in the response curve in comparison to the non-heat
shocked control (n=7, ** indicate p<0.02 repeated measures ANOVA) and
showed an increase in the FF50 of the giant fiber pathway (* indicates
p<0.05, Student's t-test). C-D) Ash218/slo4 transheterozygotes do not express
slowpoke in the nervous system and sedation did not affect the frequency
response curve nor the FF50 of their giant fiber pathway.
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Induction of slowpoke enhances excitability of the giant fiber pathway
In order to test if the slowpoke induction by itself was sufficient to phenocopy
the electrophysiological effect of sedation on the following frequency of the giant
fiber, a transgenic fly carrying an inducible copy of a slowpoke cDNA was used. With
this transgene one can temporally control the time of induction by giving a brief heat-
shock to the flies which resembles a benzyl alcohol treatment both in duration and in
timing of the event, 24 hours prior to testing in this case. This form of induction has
been shown to produce levels of slowpoke that mimic those induced by benzyl
alcohol as well as confer increased resistance to the drug compared to non heat-
shocked control in a way that resembles tolerance to the drug (Ghezzi et al., 2004).
A single heat pulse caused B52 flies to show an increase in neuronal following
frequency with a shift in the response curve slightly to the right (Figure 5.4A) and an
average increase in the FF50 of 21 hertz or 15% over the nontreated control (Figure
5.4B). However, when non-transgenic control animals are subjected to the same heat
pulse they do not show an increase in following frequency (Figures 5.4C and 5.4D).
In fact, these flies show a non-significant but notable decrease in the number of
successful responses after electrical stimulation compared to non heat-shock controls.
This result is not surprising since it was previously shown that heat-shock by itself
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Figure 5.4: Transgenic induction of slowpoke expression increases the
following frequency. Sets of three trains of ten stimuli where delivered at
different test frequencies through stimulation on the eyes (SL) to animals that
were heat-shocked (37°C) for 30 minutes 24 hours earlier (open boxes) or
age-matched controls that were not heat-shocked (closed circles). The number
of responses (out of a total of 30 possible) at each frequency were counted and
plotted against frequency (A and C). Additionally, the following frequency
with 50% response (FF50) for each animal was calculated by interpolation (B
and D). A-B) In B52H flies, heat shock induction of the B52H transgene
shifts the response curve slightly to the right in comparison to the non-heat
shocked control (** indicate p<0.01, n=27 HS, 22 No HS, repeated measures
ANOVA) and induces a significant increase in the FF50 (* indicate p<0.02,
Student's t-test). C-D) The same heat shock protocol does not produce a




The strong link between an increase in the expression of the slowpoke gene
and the development of tolerance to sedation suggests that at a functional level, the
up-regulation of slowpoke is part of homeostatic response that enhances net neural
excitability and thereby helps the nervous system to resist sedation and leads to drug
tolerance in flies. Data presented here is consistent with the idea that increased neural
expression of slowpoke, is in some respect, a neural excitant. This is an unusual role
to postulate for a K+ channel. Certainly, in some preparations, increased BK channel
activity clearly reduces neural excitability (Sun and Dale, 1998; Orio et al., 2002;
Gribkoff et al., 2001). However, in other preparations, BK channel activity has been
positively correlated with neural excitability (Warbington et al., 1996; Lovell and
McCobb, 2001; Van Goor et al., 2001; Pattillo et al., 2001). It has been proposed that
the increase in BK channel activity limits the instantaneous response of the cell, it
augments the capacity for repetitive neural activity by reducing the neural refractory
period (Warbington et al., 1996; Lovell and McCobb, 2001). The refractory period is
the period of time that must elapse before the neuron can fire again. 
Drosophila is a difficult organism in which to do central nervous system
electrophysiology. However, the giant fiber pathway is well suited for this particular
question. The giant fiber synapses with an interneuron that connects to a motor
neuron which triggers a response from a muscle fiber. Thus, muscle recordings report
the firing pattern of the giant fiber pathway. When stimulated with low potential used
to activate the forebrain, a so-called long-latency response can be triggered. In these
case, the remainder of the brain actively propagates the signal before it activates the
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giant fiber. However, by using a higher stimulation potential one can, in essence,
stimulate the entire brain and directly activate the giant fiber. This results in what is
called the short-latency response. Direct stimulation of the giant fiber is easily
confirmed by noting the latency of the response. In this study, the use of the short-
latency response was preferred since it provides a better defined CNS circuit. The
refractory period of these neurons determines the capacity of the giant fiber pathway
for repetitive activity.
Prior sedation of flies increases the following frequency of the short-latency
response of the giant fiber pathway. This enhancement is slowpoke dependent in that
mutations in slowpoke block it. Most importantly, it can also be produced by the
induction of slowpoke expression from a transgene. This unambiguously indicates
that an increase in slowpoke neural expression is sufficient to reduce the refractory
period of the pathway.
Although the enhancement in following frequency caused by the transgene is
less than that caused by sedation. In general, the transgene produces higher levels of
slowpoke expression than that produced by sedation of wild type flies (Ghezzi et al.,
2004). This might indicate that sedation also enhances following frequency by a
secondary means that is independent of the slowpoke gene. Alternatively, sedation
might produce more expression in the giant fiber pathway than does induction of the
transgene. Unfortunately, all of the measurements of slowpoke expression are from
the nervous system in general. It is not yet possible for us to measure expression
levels specifically in the giant fiber pathway.
It is expected that an acquired enhancement in repetitive firing, as the one
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induced by prior sedation and/or slowpoke up-regulation, results in a decrease in the
immediate effects of sedation causing increased resistance. Interestingly, experiments
by Lin and Nash (1996) have demonstrated that the giant fiber pathway is sensitive to
sedation by general volatile anesthetics. Specifically, it was reported that the
following frequencies of the long and short latencies drop significantly during
anesthesia. However, it was also noted that the sensitivity to anesthetics of the two
responses differed substantially. The long latency response was potently inhibited at
concentrations which are comparable to those needed to interfere with postural
control, whereas the short latency was only inhibited at much higher doses. 
It has being proposed, that the difference in sensitivity may be revealing of
neural components in the brain that are more sensitive to anesthetics than those down
stream. However, this may very well be due to the increased complexity of the circuit
involved in the long latency response. Indeed, most behavioral and physiological
indicators of sedation at clinically-relevant doses of anesthetics such as complex
coordination of sensory and motor systems implicate more complex neuronal
assemblies than the giant fiber circuit involved in the short latency response and
therefore it is not surprising that these physiological indicators are more susceptible to
anesthetics.
One can argue that a neural circuit with a higher number of synapses is more
liable to fail or be disrupted. In fact, even in the absence of anesthetics, the long
latency response is considerably more delicate than the short latency response, with
following frequencies as low as 2 hertz (Lin and Nash, 1996). On the contrary, the
short latency response, involves only three neural connections (one electrical synapse,
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one chemical synapse and one neuromuscular junction) and can follows stimuli in
excess of 100 hertz.
Although, functional tolerance to any drug is likely to involve a great many
neural components and in certainly other genes have been implicated in the
production of tolerance to drugs such as ethanol (Wen et al., 2005; Berger et al.,
2004; Dzitoyeva et al., 2003; Park et al., 2000), the slowpoke gene is uniquely
positioned to be a homeostatic regulator of neural excitability. The encoded channel
has one of the highest conductance of any neural ion channel, thus small changes in
its density, caused by its transcriptional response to sedation, can have a large
influence on membrane excitability. In conclusion, it is proposed that sedation causes
changes in the slowpoke expression causes a significant increase in the excitability of




Drosophila stocks used in this study were Canton S (wild type), B52H, w1118,
slo4 and the ash218/slo4 trans-heterozygote. The genotype of the B52H transgenic
stock is w1118, B52H, slo4. In the B52H transgene, an inducible hsp70 promoter drives
expression of a slowpoke cDNA whose splice pattern is found in the nervous systems
and muscles (Atkinson et al., 1998). The B52 transgene is constitutively active but is
substantially induced by a brief heat shock. Flies were raised on standard cornmeal/
molasses/agar medium at room temperature (25°C) in a room with circadian control
of illumination (12 light, 12 hours dark). Flies that emerged from pupae were
collected over a 24 hour period, transferred to fresh food, and studied three to four
days later.
Benzyl alcohol treatment and slowpoke induction
Benzyl alcohol exposure was performed by coating 30 ml glass vials with 200
ul of a solution of benzyl alcohol in acetone ( 0.4%). These experiments included an
acetone control. The vials were continuously rotated for 45 minutes at 22°C to
evaporate the acetone, leaving a thin coat of evenly distributed benzyl alcohol. Ten to
fifteen age-matched female flies were placed in each vial and exposed to the benzyl
alcohol until sedation (10 to 15 minutes). 
Expression of slowpoke was induced from a HSP70:slo transgene in the B52H
flies by placing them in a 37°C humidified incubator for 30 minutes. Mock induction
100
was performed with w1118 flies in the same way. 
Fly set-up for electrophysiology
Individual adult female flies were placed in a small centrifuge tube and briefly
anesthetized by placing the tube in ice for exactly 3 minutes. The sedated fly is
dropped over a small mount of bee's wax on a microscope slide. Using fine forceps,
the fly is fixed in place before it wakes up by embedding it's legs in the wax so that
the fly has a natural standing position (horizontal - dorsal side up) but is unable to
walk or fly away (Figure 5.5A). The head and thorax are glued together to prevent
movement by application of small amounts of superglue using a pulled thin capillary
tube. After drying for three minutes, small drops of conducting gel (Signa Creme,
Parker Laboratories, Inc., Fairfield, NJ) were applied to the eyes using a syringe with
a gauge 27.5 needle (Figure 5.5B). For experiments that involve treatments with
anesthetics or heat-shock, flies were treated 24 hrs prior to the recordings and
returned to food vials for recovery. Both, benzyl alcohol and heat-shock treatments
were performed at mid day (6th hour of light).
The fixed fly was transferred to a 3X magnification stereoscope stage that is
set over a air table. Electrodes were inserted in the fly using micromanipulators
(Narishige, Tokio, Japan) that were also set over the air table. All electrodes were




Figure 5.5: Fly set-up for electrophysiological stimulation and recording.
A) Picture of a fly fixed in a wax mount. Legs are embedding in the wax so
that the fly has a natural standing position (horizontal - dorsal side up) but is
unable to walk or fly away. B, C, D) Sequential pictures of a fly during the
application of small drops of conducting cream using a syringe with a gauge
27.5 needle. 
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A 200 um diameter stimulating electrode was placed into the conductive gel
on each eye at an angle of approximately 45 degrees to the anterior posterior axis of
the fly so that it is perpendicular to the tangent of the center of the eye (Figure 5.6).
When inserted, the electrode tips are immersed in the conducting cream covering the
eyes and make contact with the surface of the eye, but do not pierce the eye. A 75 um
diameter recording electrode was inserted coming dorsally, parallel to the anterior-
posterior axis of the fly (when viewed from the top) but at a 45 degree angle above
the plane of the microscope stage (Figure 5.6). The electrode is inserted through the
cuticle slightly to the right of the center of the line that divides the notum and the
scutellum into the right-uppermost dorsolongitudinal muscles (DLM) that lies just
beneath the cuticle. A 200 um diameter reference electrode was inserted into the
abdomen coming at 45 degrees above the plane of the microscope stage and 45
















Figure 5.6: Set-up of the electrophysiology stage. A fly that has been fixed
on a wax mount is placed on a stereoscope stage. Electrodes are positioned in
the fly at the angles shown using micromanipulators A) Top view of the
recording stage. B) Side view of the recording stage. 
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Electrophysiology
Stimulating potentials of 0.1 ms duration were generated using a S48 square
pulse stimulator, isolated with a SIU5 Stimulus Isolation Unit (Grass-Telefactor,
West Warwick, RI). Responses from the DLM muscles were amplified with a
Microelectrode Amplifier Model 1800 (A-M systems, Inc., Carlsborg, WA), digitized
by a DigiData 1200 (Axon instruments, Sunnyvale, CA) and recorded for analysis on
a PC using FETCHEX, pCLAMP 6 software (Axon instruments, Sunnyvale, CA).
For determining latencies, a stepping protocol was employed. In this protocol
a 10 volt stimulus, 0.1 ms in duration, is delivered and the muscle response recorded.
The voltage is then increased by two volts and another 0.1 ms stimulus is delivered.
The process is repeated until the stimulating voltage reaches 30 volts. Latencies of the
responses from each stimulus are measured using FETCHEX, pCLAMP 6 software
(Axon instruments, Sunnyvale, CA) from the beginning of the stimulus artifact to the
beginning of the evoked muscle response. Results are represented as a voltage/
latency plot for each fly tested.
For high frequency stimulation, single stimuli, 0.1 ms in duration, of
increasing amplitude were first delivered to the eyes until a response with a constant
short latency of approximately 1.4 ms was detected. A short latency response is
indicative of direct stimulation of the giant fiber pathway. While determining the
following frequency (see below), the stimulation potential was four volts over the
short latency threshold in order to insure that the giant fiber pathway was always
directly activated. For direct muscle stimulation, two stimulating electrodes were
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inserted laterally (one from each side of the fly) into the thoracic-abdominal ganglion
and stimulated at 5 volts.
Following frequency was determined with a stimulus paradigm that consisted
of three trains of ten stimuli at each test frequency, with five seconds between trains.
The stimulus frequency was increased by 20 Hz after each three train test, starting at
40 Hz up to 220 Hz for short latency stimulation and up to 400 Hz for direct muscle
stimulation. The number of stimulus responses detected in the muscle (out of 30)
were counted for each frequency. Averaged responses were plotted against frequency
to generate a frequency response curve. Two-way repeated measures ANOVA was
used to determine significance, although the error bars in the figures are SEM for each
point. All recordings were performed at the same time of day (around the sixth hour
of light according to the flies circadian lighting). 
For each fly, following frequency with 50% response (FF50) was
independently calculated from the linear phase of the frequency response curves by
linear interpolation of the frequency that elicited 15 responses (Engel and Wu, 1992).
Significance was determined by Students t-test.
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Chapter 6: Summary and Conclusion
The ability of the nervous system to generate carefully coordinated
movements, perform complex computational tasks or exercise precise control over
several physiological functions, relies on an exquisitely controlled balance between
excitatory and inhibitory signals within and between nerve cells. The perturbation of
this balance, will often result in the aberrant functioning of these processes. Many
volatile solvents can produce significant alterations in the activity of the nervous
system causing severe physiological and behavioral effects that range from
uncontrolled hyperactivity to profound sedation. These attributes have led to the use
of organic solvents as valuable clinical anesthetics in some cases or as detrimental
drugs of abuse in other unfortunate cases.
Upon alteration of neural activity by these drugs, the nervous system triggers
homeostatic mechanisms which ensure that the activity returns to reasonable
physiological limits, thus preventing individual neurons from firing excessively or
become completely silent. These changes can occur as either fast and transient
responses that oppose the immediate effects of the perturbations or as slow and long-
term adaptive processes which prepares the system for future perturbations. In the
case of drug induced alterations of activity, homeostatic long-term neural adaptations
are often manifested in the form of tolerance. In this study, tolerance was defined as
an acquired decrease in sensitivity to the effect of a drug that results from prior
exposure to that drug. 
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Since the excitability properties of neurons are determined by the types,
distribution, and density of ion channels they express, changes in the expression of
channels genes can affect cell resting potentials, action potential threshold and
duration, repetitive firing, and neurotransmitter release. Here, it was hypothesized that
modulation of ion channel genes may represent a homeostatic mechanism that
underlies tolerance to drugs. Using a Drosophila model system to investigate the
molecular mechanism behind this phenomenon I have shown that changes in the
expression of the calcium-activated, voltage-gated potassium channel gene slowpoke
result in changes in the excitability of the nervous system and leads to tolerance to
sedation.
First we have seen that exposure of fruit flies to solvent anesthetics results in a
brief initial phase of exaggerated locomotor activity followed by a long period of
deep sedation, effects that remarkably parallel those observed in higher organisms
including humans. Interestingly, exposure to these drugs also results in the
modulation of expression of the slowpoke gene. In these studies it was shown that the
induction of slowpoke expression by a drug is closely linked to the level of activity
induced by the drug. Drugs or doses that induce sedation also induce slowpoke
expression, while drugs or doses that induce hyperactivity cause a decrease in
slowpoke expression. This data suggests that the transcriptional regulation of
slowpoke is under control of activity-dependent mechanisms that can monitor and
respond to changes in activity induced by the drug rather than to the presence of the
actual drug.
Second, flies as well as humans, may develop tolerance to more than one
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effect of these drugs. One particular effect that was extensively studied here, is the
duration of sedation induced by these drugs. After a single exposure to benzyl alcohol
flies will recover faster from the sedative phase of a second intoxication by the same
drug. Interestingly, the development of tolerance to sedation in flies is dependent on
slowpoke expression. A mutation that eliminates slowpoke expression in all tissues or
specifically in the nervous system of Drosophila, also eliminates the appearance
tolerance, while artificial induction of slowpoke expression using an inducible
transgene will cause resistance to sedation in naïve flies.  
Furthermore, the activity-dependent increase in slowpoke expression induced
by several drugs directly correlates to an the increase in resistance to sedation that
results in tolerance. This correlation holds true when slowpoke expression is induced
by the same anesthetic, a different anesthetic or even when artificially induced using
transgenic tools. It was observed that related drugs that display similar acute effects
and induce expression of slowpoke will also show cross-tolerance. Cross-tolerance is
the reduction in sensitivity to the effects of one drug after prior exposure to the
another drug. In fact, cross-tolerance to benzyl alcohol was induced not only by
chloroform, another solvent anesthetic; but was also induced by the non-solvent
anesthetic CO2. Both chloroform and CO2, induce deep sedation in flies. On the
contrary, the solvent toluene or a brief heat-shock, both of which cause hyperactivity
in flies, will induce an increase in the duration of benzyl alcohol sedation after prior
exposure to toluene or to a heat-shock (cross-sensitization). 
These observations are clear indicators of homeostatic response to the effects
of these treatments on neural excitability and not to drugs themselves and implicate
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slowpoke as a key player in the homeostatic mechanism that results in drug tolerance.
Although, it is likely that slowpoke is one component of an orchestrated
response of transcriptional changes and post-transcriptional modifications that
involves many genes, sedation does not evoke this response from all ion channel
genes. Neither the Shaker or seizure voltage-gated K+ channel nor the para voltage-
gated Na+ channel transcripts shows a significant increase in expression following
sedation. Although it is clear that mutations in several other ion channels genes affect
the level of sensitivity to specific pharmacological effects of solvent intoxication,
changes in the expression patterns of the other genes are not required for developing
tolerance. 
This data argues that the principle behind tolerance does not revolve around
set levels of sensitivity or resistance towards a specific drug. Rather, tolerance
implicates the capacity to produce significant changes in sensitivity in an experience
dependent manner. Interestingly, the ion conductance for slowpoke channels are up to
10 times larger than all of the channels tested. A change in slowpoke alone would thus
have a greater impact on the excitability of a neuron, making it a reasonable choice
for generating large changes in cellular excitability at a lower transcriptional cost.
Although the mechanisms by which the changes in activity translate into changes in
slowpoke expression are still inconclusive, there is enough evidence to suggest that
multiple signal transduction pathways are involved, including the well studied
transcription factor CREB and the clock gene period.
The large-conductance calcium-activated potassium channels (BK), encoded
by slowpoke, have been shown to participate in regulating neuronal firing patterns and
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neurotransmitter release. Electrophysiological data presented here is consistent with
the idea that increased BK channel expression from the slowpoke gene enhances net
neural excitability and thereby helps the nervous system to resist sedation. Increased
neural expression of slowpoke is, in some respect, a neural excitant, it augments the
capacity for repetitive neural activity presumably by reducing the neural refractory
period.
In conclusion, I postulate that the sedation-induced changes in slowpoke
expression reflect a homeostatic mechanism that resists untoward changes in net
cellular excitability. If hyperexcitability is induced, an activity-dependant mechanism
alters channel expression to reduce this excitability, whereas if cellular excitability is
suppressed, channel gene expression changes to enhance excitability. This
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